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ABSTRACT  
 
ATP-sensitive K+ channels (KATP) channels were first described in the cardiac 
muscles. KATP channels are a complex of regulatory sulphonylurea receptor subunits and 
pore-forming inward rectifier subunits such as Kir6.1. Nicotine, an exogenous 
substance, adversely affects cardiovascular function in humans. Acetylcholine (ACh) is 
well known as a key neurotransmitter of he parasympathetic nervous system. ACh 
effects are usually related to binding to muscarinic receptors and stimulating second 
messengers that relay and direct the extracellular signals to different intracellular 
destinations, resulting in modulated cellular activity. We hypothesize that nicotine and 
ACh may modulate Kir6.1 channels via different mechanisms. Using the whole cell 
patch-clamp technique, the interactions of nicotine and ACh with Kir6.1 subunit 
permanently expressed in Human Embryonic Kidney (HEK-293) cells as well as the 
underlying mechanisms were studied.  
Non-transfected HEK-293 cells possess an endogenous K+ c rrent with current 
density of –3.2 ± 1.4 pA/pF at –150 mV (n = 9). Stable expression of Kir6.1 subunits 
cloned from rat mesenteric artery in HEK-293 cells yielded a detectable inward rectifier 
KATP current (-23.9 ± 1.6 pA/pF at –150 mV, n = 6). In the presence of 0.3 mM ATP in 
the pipette solution, nicotine at 30 and 100 µM increased the expressed Kir6.1 currents 
by 42 ± 11.8 and 26.2 ± 14.6%, respectively (n = 4-6, p<0.05). In contrast, nicotine at 1-
3 mM inhibited Kir6.1 currents (p<0.05). Nicotine at 100 µM increased the production 
of superoxide anion (O2.-) by 20.3 ± 5.7% whereas at 1 mM it significantly decreased the 
production of O2.- by 37.7 ± 4.3%. The hypoxanthine/xanthine oxidase (HX/XO) 
reaction was used as a source of O2.-. Co-application of HX and XO to the transfected 
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HEK-293 cells resulted in a significant and reproducible increase in Kir6.1 currents. 
Tempol, a scavenger of O2.-, abolished the stimulatory effect of HX/XO on Kir6.1 
currents. Tempol also abolished the stimulatory effect of 30 mM nicotine on Kir6.1 
currents (-28.3 ± 6.1 pA/pF vs. -31.2 ± 7.3 pA/pF at -150 mV, n = 6-9 for each group, 
p>0.05).  
In the presence of 0.3 mM ATP in the pipette solution, ACh concentration-
dependently increased the expressed Kir6.1 currents. At 1 µM, ACh increased Kir6.1 
currents from -19 ± 2.5 to – 31.7 ± 2.1 pA/pF (n = 8, p < 0.05). Pretreatment of the 
transfected HEK-293 cells with either 2 or 20 µM atropine, 100 nM a-bungarotoxin, 
100 µM mecamylamine, 2 µM prazosin, 1 µM propranolol, or 10 µM dihydro-b-
erythroidine hydrobromide did not alter the stimulatory effect of ACh on Kir6.1 currents 
(n = 4 - 5 for each group, p<0.05). When intracellular ATP was increased to 5 mM, ACh 
at 10 µM still exhibited its stimulatory effect (-16.4 ± 2.3 to –25.5 ± 3.8 pA/pF, n = 8, 
p<0.05).  For the first time, the present study provides an insight for the interactions of 
nicotine and ACh with Kir6.1 subunits. Our data demonstrate that micromolar 
concentration of nicotine and ACh stimulated Kir6.1 channels. Nicotine at millimolar 
concentrations inhibited Kir6.1 channels. The dual effect of nicotine, not mediated by 
nAChR, are mediated partially by O2.- levels in the cells. The ACh excitatory effect is 
mediated neither by an AChR-dependent mechanism, nor by alteration in ATP 
metabolism. This study challenges the traditional explanations for the receptor-mediated 
effects of nicotine and ACh on ion channels and opens a new door to understand the 
effects of nicotine and ACh on KATP channels in many cellular systems.  
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1. GENERAL INTRODUCTION  
 
1.1.  K ATP CHANNELS 
 
ATP-sensitive K+ channels (KATP channels) were first described in the cardiac 
muscle by Noma (1983) and were characterized by inhibition when the ATP 
concentration at the cytoplasmic surface was increased to millimolar levels (Ammala et 
al., 1996a). Subsequently, KATP channels were found in various tissues, including 
pancreatic b-cells, skeletal and smooth muscle, pituitary, and brain. KATP cha nels 
couple the cell’s metabolic status to its electrical activity and play an important role in 
various cellular functions as sensors of intracellular ATP and ADP (Fig. 1.1) (Seino and 
Miki, 2003). In pancreatic b-cells, the increase in ATP/ADP ratio generated by glucose 
stimulation closes the KATP channels to elicit the secretion of insulin, the primary 
hormone of glucose homeostasis (Ammala et al., 1996b). Thus KATP channels are crucial 
in the regulation of glucose-induced insulin secretion. They also are the targets for 
sulphonylureas, insulin secretagogues widely used as oral hypoglycemic agents in the 
treatment of non-insulin-dependent diabetes (NIDDM). KATP channels in cardiac and 
skeletal muscle have been implicated in cell excitability, cytoprotection, and the cellular 
loss of K+ during ischemia, hypoxia, or other metabolic insults (Ammala et al., 1996a). 
In brain, KATP channels are involved in neuronal excitability and appetite control, and in 
cytoprotection in ischemia and hypoxia. KATP channels also have been implicated in 
other functions, including smooth musclerelaxation and vasodilatation, secretion of 
pituitary hormone, K+ recycling in renal epithelia, and oocyte maturation (Nelson and 
Quayle, 1995).  
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Figure 1.1. KATP channel as metabolic sensor. KATP channels play an important role 
in the cellular responses of various tissues to alt red metabolic states, including 
hyperglycemia, hypoglycemia, ischemia, and hypoxia. 
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Electrophysiological studies have shown that the kinetics and pharmacological 
properties of KATP channels vary among different tissues, suggesting structurally and 
functionally distinct types (Cao et al., 2002; Ammala et al., 1996b). KATP channels are a 
complex of the Kir6.x subunit, a member of the inwardly rectifying K+ cha nel family, 
and the sulphonylurea receptor (SUR) subunit, a member of the ATP-binding cassette 
(ABC) superfamily (Cao et al., 2002). Various combinations of the Kir6.x subunit with 
SUR subunits have been shown to reconstitute the functionally diverse KATP chann ls.  
 
1.2. PROPERTIE S OF KATP CHANNELS IN NATIVE TISSUES 
 
1.2.1. Biophysical properties of KATP channels 
KATP channels are highly selective for K+ and Rb+ and have a relative 
permeability to Na+ over K+ (PNa/PK) of ~0.01. The current-voltage relationships of KATP 
channels show the property of weak inward rectification, the outward current being 
smaller than the inward current (Inagaki et al., 1995). The inward rectification of KATP 
channels is due to a voltage-dependent block of outward currents by internal cations 
such as Mg2+ and Na+. Single channel conductance measured in the inside-out
configuration ranges from ~50 to 75 pS in pancreatic b-cells nd ~70 to 90 pS in cardiac 
cells for inward currents under symmetrical K+ conditions of 140 mM on both sides of 
the membrane (Inagaki et al., 1996). A fundamental characteristic of KATP hannel 
openings is that they are time-independent, occurring in clusters of bursts separated by 
relatively long closed periods (Inagaki et al., 1995). Time constants for the open times 
and closed times within the bursts are ~2 to 3 ms, and 0.3 to 0.5 ms, respectively.    
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1.2.2. Regulation of KATP channels by ATP and ADP 
When applied to the cytosolic side of the membrane, ATP inhibits KATP channels 
in a dose-dependent manner. A complete block of KATP channels is observed at 
millimolar concentrations of ATP, which affects channel kinetics by reducing the 
number of openings per burst and increasing the duration of the closed intervals between 
bursts. ATP has no effect on the amplitude of single-channel currents (Nelson and 
Quayle, 1995). 
ATP has two effects on KATP channels: inhibiting channels activity and 
maintaining the channel in anoperative state (Cao et al., 2002). Since the inhibitory 
effect can be observed also with nonhydrolyzable analogues of ATP s ch as adenylyl 
imidodiphosphate (AMP-PNP) and adenylylmethylenediphosphate (AMP-PCP), and by 
ATP in the absence of Mg2+ (ATP4-), it has been thought that the hydrolysis of ATP and 
phosphorylation of the KATP channel is not necessary for the inhibition by ATP. One 
important property of KATP channels is the gradual inactivation that follows patch 
excision in an ATP-free medium; a process known as “channel run down” (Okuyama et 
al., 1998). Exposure of the patch to MgATP can prevent a rundown of the KATP channels 
and also can “refresh the activity” of the rundown KATP channels. Furthermore, 
nonhydrolyzable ATP analogues do not substitute for MgATP in the maintenance of 
KATP channel activity. These findings suggest that hydrolysis of ATP or phosphorylation 
of the KATP channel is required to maintain the channels in an operative state. 
On the other hand, the inhibitory action of ATP is reduced in the presence of 
MgADP. The cytoplasmic ATP/ADP ratio that reflects the metabolic status of the cell is 
thought to be more important for the regulation of KATP channels than the ATP 
concentration by itself in regulating channel activity in intact cells. The stimulatory and 
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inhibitory effects of the nucleotides on the KATP channels have been proposed to be 
mediated through two nucleotide-binding sites present in KATP channel. A high 
concentration of ADP in the absence of Mg2+ (ADP3-), when applied to the cytoplasmic 
surface of excised membrane patches can inhibit KATP c annel activity, suggesting that 
ADP3- binds to the same site as ATP4- does in the KATP channel.  
 
1.3. MOLECULAR STRUCTURE AND FUNCTIONAL DIVER SITY OF K ATP 
CHANNELS 
 
1.3.1. The inwardly rectifying K+ channel family 
Inwardly rectifying K+ channels are distinct from voltage-gated K+ (Kv) channels 
because they are not activated by membrane depolarization and because they allow a 
larger K+ influx than they do an efflux (Jan and Jan, 1997). However, the structure of the 
inwardly rectifying K+ channel was unknown until 1993. 
In 1993, Ho et al. and Kubo et al. reported the expression cloning of cDNA 
encoding distinct inwardly rectifying K+ channels. These studies led to the elucidation of 
the structure and function of the subfamily of inwardly rectifying K+ channels. The 
inwardly rectifying K+ channel proteins so far identified vary from ~ 360 to 500 amino 
acids long, and the amino acid identity is ~ 40% between members belonging to 
different subfamilies and ~ 60% between individual members within each subfamily. At 
least 7 subfamilies are now identified designated Kir1.0 - 7.0, in the inwardly rectifying 
K+ channel family (Okuyama et al., 1998). A hydropathy profile of the proteins predicts 
the presence of two transmembrane domains (M1 and M2) in Kir channels (Fig. 1.2), a 
feature different from Kv channels, which have six transmembrane domains (Ho et al., 
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A.  
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. Molecular structure of KATP channel. (A) Assembly of KATP channel. The 
KATP channel compris of two subunits: Kir6.x (Kir6.1 or Kir6.2) and the regulatory 
subunit sulphonylurea receptor SUR (SUR1 or SUR2). (B) Membrane topology of SUR 
and Kir6.x. The sulphonylurea receptor has been proposed to have seventeen 
transmembrane domains. Kir6.x has two transmembrane domains (M1 and M2). 
Abbreviations:  NBD1 and NBD2, nucleotide binding domains 1 and 2; TMD, 
transmembrane domains). (Gros et al., 2002)         
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1993). However, Kir6.x channels retain the highly conserved H5 (or P) region between 
the two transmembrane domains (Yang et al., 1995; Ashcroft and Gribble, 1998).  
Hydropathy analysis and epitope labelling suggests that SUR subunits have 
seventeen transmembrane domains (TMDs). These may be grouped into three sets 
(TMD 0, 1, 2), consisting of 5, 6 and 6 transmembrane domains, respectively (Cao et al., 
2002). Like other ABC transporters, SUR has two large cytosolic loops referred to as 
nucleotide binding domains (NBD1 and NBD2) that contain consensus sequences for 
Mg-nucleotide binding and hy rolysis. Interaction of nucleotides with the NBDs 
stimulates channel activity. The sulphonylurea receptor SUR contains the binding sites 
for sulphonylureas and KCOs and endows the KATP channel with sensitivity to both 
groups of drugs. Kir6.x has no obvious consensus site for nucleotide binding; 
nevertheless, it is now clear that Kir6.x forms the KATP channel pore and contains the site 
at which ATP mediates channel inhibition. Considering its high degree of amino acid 
sequence similarity to the H5 region of Kv channels, it is likely that the H5 region of Kir 
channels also is responsible for K+ selectivity. Several lines of evidence indicate that the 
inwardly rectifying K+ channels are composed of homomeric or heteromeric tetramers of 
the channel subunits (Sun et al., 2004). 
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Table 1.1.  Reconstitution of KATP channels from SUR subunit and Kir6.x subunit 
         
                              Properties  
Type of KATP channel       
 
 
Vascular smooth   SUR2B+Kir6.1  (-)            (+)        undetermined    
muscle type 1   
 
Retinal glial cells2  SUR1+Kir6.1  (+)      undetermined   undetermined   
     
SUR2A+Kir6.1 (+)      undetermined   undetermined   
 
 
Smooth muscle type 3  SUR2B+Kir6.2  (+) low (+)  (+)
  
 
Cardiac and skeletal   SUR2A+Kir6.2 (+) low (+) low (-) 
muscle type 4 
 
Pancreatic b-cell type 5 SUR1+Kir6.2  (+) high (+) high (+) 
 
References: 
1 Yamada et al., 1997 
2 Skatchkov et al., 2001 
3 Isomoto et al., 1996  
4 Inagaki et al., 1996 
5 Inagaki et al., 1995; Sakura et al., 1995 
 
 
   
Subunit  
combination ATP 
sensitivity 
Glibenclamide 
sensitivity 
Diazoxide 
sensitivity 
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1.3.2. Kir6.1 channels 
Inwardly rectifying K+ channels allow K+ ions to enter the cell much more 
readily than they do K+ permeation in the opposite direction, regardless of the K+ 
concentration in the external solution and hence of the K+ quilibrium potential. Thus, 
inwardly rectifying potassium channels appear to be sensitive to the electrophysiological 
driving force for K+ ions. These channels play a significant role in determining the 
resting potential of the cell and may be sensitive to the electrochemical driving force for 
K+ ions (Ammala et al., 1996a).     
Inwardly rectifying K+ channels (Kir) have many important physiological roles. 
Based on sequence similarity, the Kir family currently is divided into seven subfamilies, 
Kir1.x through Kir7.x. Kir6.x subfamily members, including Kir6.1 (originally termed 
uKATP) encoded by potassium inwardly-rectifying channel, subfamily J, member 8 
(Kcnj8) and Kir6.2 (originally termed BIR)encoded by potassium inwardly-rectifying 
channel, subfamily J, member 11 (Kcnj 1). There are two isoforms of the gene encoding 
SUR, SUR1 (also known as Abcc8) and SUR2 (Abcc9). In addition, there are several 
splice variants of SUR2, the major ones being SUR2A and SUR2B. Reconstitution 
studies have shown that different combinations of Kir6.1 or Kir6.2 and SUR1 or SUR2 
variants generate K+ currents (Table 1.1) with distinct nucleotide sensitivity and 
pharmacological properties (Giblin et al., 2002a,b). 
Although the electrophysiological and pharmacological properties of Kir6.2-
containing K+ channels have been well characterized in reconstituted systems and native 
tissues, those of Kir6.1-containing K+ channels are not fully understood. Co-expression 
of Kir6.1 and SUR1 in HEK-293 cells produces tolbutamide-sensitive K+ channel 
currents, whereas co-expression of Kir6.1 and SUR2A in COS7 cells produces currents 
  10 
responsive to very high concentrations of nucleoside diphosphate (UDP); however, their 
physiological significance is unknown (Giblin et al., 2002a,b)  Co-expression of Kir6.1 
and SUR2B in HEK-293T cells produces a K+ current activated by nucleotide 
diphosphates such as UDP and inhibited by the sulphony urea glibenclamide. These 
properties are similar to those of the KATP channels in native vascular smooth muscle 
(vascular KATP channel) (Ammala et al., 1996a).  Because K+ channel openers (KCOs) 
with vasodilating effects, such as cromakalim and pinacidil, open the vascular KATP
channels, the channels are thought to be involved in the vasodilation response of 
vascular smooth muscle. To clarify the physiological roles of Kir6.1-contain ng channels 
directly, mice lacking the gene encoding Kir6.1 (Kcnj8) were generated. It was shown 
that the Kir6.1-containing channel is critical n regulation of vascular tones, a d that its 
genetic disruption in mice causes sudden cardiac death (SCD) associated with 
arrhythmia nd atrioventricular (AV) block caused by spontaneous cardiac ischemia, a 
phenotype resembling that of Prinzmetal (or variant) angina in humans  (Seino and Miki, 
2003). SCD is thought to be the principle cause of unexpected, rapid death in adults and 
infants. Although most SCD occurs in patients with cardiac disease such as coronary 
atherosclerosis, myocardial disease and inflammatory cardiac disease, some occurs 
unexpectedly from abrupt cardiac arrest due to arrhythmia or myocardial ischemia. 
Genetic abnormalities of ion channels (K+, Na+ or Ca2+ channel subunits), a gap junction 
protein (connexin40) and cardiac-specific transcription factors have so far been shown to 
be involved in SCD caused by lethal arrhythmia in human and mice. Of these, 
abnormalities in K+, Na+ and Ca2+ channel affect depolarization and repolarization of 
cardiomyocytes and cause long-QT syndrome in human and mice. In cardiomyocytes 
isolated from mouse models of long-QT syndrome, abnormal ion currents were detected 
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on the plasma membrane. In Kir6.1-null mice, however, no electrophysiological 
abnormalities were found in cardiomyocytes. In addition, there were normal plasma 
membrane KATP channels in the cardiomyocytes of Kir6.1-null mice. Accordingly, 
Kir6.1 is unlikely a constituent of the plasma membrane KATP channels in 
cardiomyocytes. Together with the previous finding of the absence of plasma membrane 
KATP channels in the cardiomyocytes of Kir6.2-deficient (Kir6.2-null) mice, this 
suggests that Kir6.1-Kir6.2 heteromultimers do not form in vivo, or are of no functional 
significance, as suggested by in vitro experiments (Seino and Miki, 2003). The lack of 
abnormalities in the electrophysiological properties of cardiomyocytes of Kir6.1-null 
mice indicates that the pathophysiology of the atri ventricular (AV) block in Kir6.1-null 
mice differs from that in long-QT syndrome due to K+, Na+ or Ca2+ channel dysfunction. 
Alternatively, the AV block is caused by the spontaneous ST elevation due to the 
myocardial ischemia. In contrast to the normal lectrophysiological properties of Kir6.1-
null myocytes, it has been found that in vascular smooth muscle KATP chann ls are 
defective in aortas of Kir6.1-null mice. As the KATP channel in smooth muscle of the 
aorta is intact in Kir6.2-deficient mice, these findings indicate that Kir6.1 is a constituent 
of the KATP channels of the plasma membrane in vascular smooth muscle. The lack of 
vasodilation response to pinacidil both in vivo (blood pressure decrease) and in vitro
(relaxation of the aortic rings) indicates that Kir6.1-containing KATP channels have a 
critical role in the regulation of vascular tonus. 
The most remarkable finding in Kir6.1-null mice is spontaneous coronary spasm 
leading to lethal AV block, a phenotype resembling that of Prinzmetal (or variant 
angina) in humans. Prinzmetal angina is an unusual form of unstable angina reported by 
Prinzmetal et al. in 1959, which occurs almost exclusively at rest and is associated with 
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elevation of ST segments on electrocardiogram (ECG) during the attack. The 
pathophysiology of Prinzmetal angina is thought to include hypercontractility of 
epicardial coronary arteries with or without atherosclerotic changes. Although the attack 
disappears spontaneously in most cases, it can lead to myocardial infarction, AV block, 
life-threatening ventricular tachycardia and sudden death if the coronary vasospasm is 
prolonged. Prinzmetal angina is diagnosed by elevated ST segments on ECG during the 
attack or by induction of coronary spasm using ergot alkaloids or acetylcholine. Because 
the sudden death of Kir6.1-null mice is associated with spontaneous ST elevations 
and/or AV block, and administration of the ergot alkaloid methylergometrine elicited 
significant elevation of ST segments both in vivo and in vitro, Kir6.1-null mice can be 
proposed as an animal model of Prinzmetal angina. The depressed ST segments seen in 
Kir6.1-null mice likely reflect coronary artery spasm at different sites. The findings that 
coronary vascular resistance is elevated under basal conditions and increased markedly 
after methylergometrine application in langendorff perfused heart preparation from 
Kir6.1-null mice demonstrate directly that the disruption of Kir6.1 causes the coronary 
spasm responsible for the phenotype f Kir6.1-null mice.  
 
1.3.3. Kir6.1 channel structure 
Using GIRK1 (Kir3.1) cDNA as a probe, researchers cloned uKATP-1 (currently 
referred to as Kir6.1) from a rat pancreatic islet cDNA library. Rat Kir6.1 is a 424-amino 
acid protein that has two putative transmembrane segments (Aguilar-Bryan et al., 1998) 
(Fig. 1.3). As Kir6.1 shares only 40-50 % identity with previously cloned Kir channel 
members, it represents a new subfamily, Kir6.x. The glycine-tyrosine-glycine motif in 
the H5 region, which is critical for K+ i n selectivity and is highly conserved among K+ 
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channels, is not conserved in Kir6.1. The motif in Kir6.1 is glycine-phenylalanine-
glycine (G-F-G). The intracellular C-terminal region in human Kir6.1 has two potential 
protein kinase A-dependent phosphorylation sites (threonine-234 and serine-385) and 
seven protein kinase C-dependent phosphorylation sites (serine-224, threonine-345, 
serine-379, serine-385, serine-391, and serine-397). Kir6.1 is expressed ubiquitously, but 
it is not expressed in the insulin-secreting cell line HIT-T15 (hamster derived), RINm5F 
(rat-derived), and MIN6 (mouse-derived), all of which have KATP channels.  Studies 
using immunoblot analysis of subcellular fractions and electron microscope examination 
showed that Kir6.1 is present predominantly in the inner membrane of mitochondria 
(Seharaseyon et al., 2000; Hu et al., 1999) of cardiac myoytes. Kir6.1 protein in cardiac 
myocytes is upregulated by pinacidil, and expression of the Kir6.1 gene is induced by 
cardiac ischemia (Akao et al., 1997). The human Kir6.1 gene (Kcnj8) is mapped to 
chromosome 12p11.23. 
An isoform of Kir6.1, BIR (the b-cell inward rectifier, currently referred to as 
Kir6.2), was subsequently cloned from a human genomic library and the MIN6 cDNA 
library, using Kir6.1 cDNA as a probe. Kir6.2 is a 390-amino acid protein that shares 
71% amino acid identity with Kir6.1. Like Kir6.1, Kir6.2 has the glycine-p nylala ine-
glycine motif in the H5 region. Both Kir6.1 (residue 170) and Kir6.2 (residue 160) have 
asparagine at the corresponding position, as is f und in the weak Kir channel subunit 
Kir1.1 (residue 171).                
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A.  Kir6.1 
 
 
 
 
 
 
 
 
 
B.  Kir6.2 
 
 
 
 
 
 
 
 
Figure 1.3. Proposed membrane topology of Kir6.1 (A) and Kir6.2 (B).  Putative 
transmembrane segments (M1, M2) and pore forming region (H5) are shown. Potential 
protein kinase A- and protein kinase C-dependent phosphorylation sites (in human 
Kir6.1 and Kir6.2) are indicated by filled circles and open circles, respectively. NH3+ 
and COO- indicate the N- and C terminus, respectively.  
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1.3.4. Reconstitution of KATP channels 
Reconstitution studies with a Kir6.x subfamily subunit and a SUR subunit in 
heterologous expression systems have uggested that different combinations of the 
Kir6.1 or Kir6.2 subunits and the SUR1, SUR2, or their variant subunits (Brochiero et 
al., 2002; Noulin et al., 2001) could account in part for the molecular and functional 
diversity of KATP channels (Table 1.1). 
 
1.3.5. Reconstitution from the Kir6.1 and SUR1 subunits
Early reports indicated hat Kir6.1 alone, when expressed heterologously in 
HEK-293 cells, elicited ATP-sensitive K+ channel currents, although the currents were 
not sensitive to sulphonylureas and diazoxide (Ammala et al., 1996b). However, recent 
studies show that SUR1 is required for ATP, sulphonylurea, and diazoxide sensitivities 
and for functional expression of Kir6.1 currents when Xenopus oocytes (Ammala et al., 
1996a) or COSm6 cells (Clement et al., 1997) are used as expression systems. These 
observations suggest that the ctivity of the Kir6.1 channel requires a sulphony urea 
receptor or other modulator of the Kir6.1 channel that is present endogenously in HEK-
293 cells and not in Xenopus oocytes or COSm6 cells (Ammala et al., 1996a). Another 
possibility is that Kir6.1 requi s another subunit of the Kir channel family that is 
expressed endogenously in HEK-293 cells to form a functional K+ channel as a 
heteromultimer. Kir6.1 subunit plus the SUR1 subunit can reconstitute ATP-, 
tolbutamide-, and diazoxide-s nsitive K+ channel currents (Ammala et al., 1996a). It has 
previously been shown with immunocytochemistry studies that retinal glial cells in dult 
frogs express Kir6.1 and SUR1, while retinal neurons display Kir6.2 and SUR2A/B 
(Skatchkov et al., 2002). Using immunocytochemis ry and electrophysiology, the 
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expression of Kir6.1/SUR1 (KATP) channels in adult frog and tadpole Muller cells has 
been demonstrated. Using conditions favoring the activation of KATP channels (i.e., 
ATP- and spermine-fr e cytoplasm-dialyzing solution containing gluconate) in Muller 
cells isolated from both adult frogs and tadpoles, Skatchkov et al. (2002) demonstrated 
the following. First, using the whole-cell configuration of patch-clamp technique, they 
showed that tolbutamide, a blocker of KATP channels, blocks nearly 100% of the 
transient and about 30% of the steady-state inward currents and depolarizes the cell 
membrane by 5-12 mV. Second, inside-out membrane patches display a single-cha nel 
inward current induced by gluconate (40 mM) and blocked by ATP (200 mM) at the 
cytoplasmic side. The c annels apparently show two sublevels (each of approximately 
27-32 pS) with a total of 85 pS maximal conductance at -80 mV. Thus, functional KATP 
channels, composed of Kir6.1/SUR1, are present in frog Muller cellsand contribute a 
significant part to the whole-cell K+ inward currents in the absence of ATP. Other 
inwardly rectifying channels, such as Kir4.1 or Kir2.1, may mediate the remaining 
currents. KATP channels may help maintain glial cell functions during ATP deficiency 
(Skatchkov et al., 2002). Skatchkov et al. (2001) had shown using immunocytochemistry 
in frog retina that most members of the Kir subfamily are expressed in specific neuronal 
compartments. However, Kir 6.1, the pore-forming subunit of KATP chanels, is 
expressed exclusively in glial Muller cells. Muller cell endfeet display strong Kir 6.1 
immunolabel throughout the retina, whereas the somata are labeled only in the retinal 
periphery. The co-expression of Kir 4.1 and Kir 6.1 subunits may enable the cells to 
maintain their high K+ conductance and hyperpolarized membrane potentials both at 
high ATP levels (Kir 4.1) and during ATP deficiency (Kir 6.1) (Skatchkov et al., 2001). 
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1.3.6. Reconstitution from the Kir6.1 and SUR2B subunits
Coexpression of Kir6.1 and SUR2B produces K+ channel currents with unitary 
conductance of approximately 33 pS in the presence of pinacidil. The activity of 
SUR2B/Kir6.1 channel is inhibited by ATP only at high concentrations (> 10–4 M) but is 
stimulated at lower concentratio s (10-6 to ~ 10-4 M). Similarly, GTP stimulates and 
inhibits channel activity at higher concentrations (>10-4 M) and lower concentrations 
(10-6 to ~ 10-4 M), respectively. SUR2B/Kir6.1 channel activity is stimulated by the K+ 
channel openers pinacidil an  nicorandil. Glibenclamide inhibits nicorandil-activated K+ 
channel currents. Nucleoside diphosphates such as UDP and GDP also stimulate 
SUR2B/Kir6.1 channel activity (Nelson and Quayle, 1995).  
The Kir6.1/SUR2B channel closely resembles a K+ channel found in vascular 
smooth muscle cells which is sensitive to KCO drugs but not to ATP (Kajioka et al., 
1991; Nelson and Quayle, 1995). This channel has a conductance similar to that of the 
Kir6.1/SUR2B channel (30-50 pS in symmetrical ~145 mM K+ solutions), is 
spontaneously closed in excised membrane patches, is activated by internal nucleotide 
di- and triphosphate, and shows little or no inhibition with internal ATP. In order to 
distinguish it from the classical KATP channels, this channel is described as the 
nucleotide diphosphate-dependent K+ (KNDP) channel (Beech et al., 1993). Because the 
major effect of KCO drugs in vivo is vasodilatation, many drugs with these profiles have 
been synthesized as novel antihypertensive and/or coronary vasodilators (Weston and 
Edwards, 1992). Since cardiac and pancreatic KATP channels were the first to be 
identified as targets for KCO drugs, the fact that the KATP channel lacks ATP sensitivity 
has posed a dilemma for the identification of the KCOdrug target in smooth muscle 
cells (Weston and Edwards, 1992). This discrepancy may have occurred because the 
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KATP channel and KNDP channels are structurally related. In particular they share the 
SUR, which appears to be responsible for the common pharmacology of the channels, 
while differing in their Kir subtypes, which provokes an entirely different sort of 
response to intracellular nucleoside triphosphate as well s single-channel behavior.  
      
1.4.      NICOTINE 
 
1.4.1. Introduction to nicotine 
Chemicals with behavioral and physiological activity are delivered to tobacco 
users when they smoke a cigarette or use other tobacco products. Whether these 
chemicals are absorbed in quantities that are of biological significance and whether such 
absorption is related to the behavior of the tobacco users are critical issues in 
understanding their role in addictive tobacco use. The scientific study of the absorption 
process, distribution within the body, and elimination from the body of drugs and 
chemicals is called pharmacokinetics. The study of drug and other chemical actions on 
the body, over time, is called pharmacodynamics. The pharmacokinetics and 
pharmacodynamics of some tobacco smoke constituents, par c larly nicotine, have been 
extensively studied. These studies show an orderly relationship between the use of 
tobacco and the absorption of nicotine. Research shows that nicotine is well absorbed 
from tobacco; that it is distributed rapidly and in biologically active concentrations to 
body organs, including the brain; and that nicotine is the major cause of the predominant 
behavioral effects of tobacco and some of its physiologic consequences. O e eff ct of 
nicotine, development of tolerance to its own actions, is similar to that produced by 
other addictive drugs. Tolerance refers to decreasing re ponsiveness to a drug or 
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chemical such that larger doses are required to produce the same magnitude of effect. 
Tolerance to many actions of nicotine occurs in animals and humans. 
Smoking adversely affects the cardiovascular system in human subjects. 
Smoking is associated with an increased risk of atherosclerotic vascular disease, 
hypertension, myocardial infarction, unstable angina, sudden cardiac death, and stroke 
(Winniford, 1990).  The adverse effects of smoking on vascular function have been 
examined in human subjects.  These studies have shown that acute and chronic cigarette 
smoking impairs nitric oxide synthase-mediated relaxation of large blood vessels (Zeiher 
et al., 1995).  In addition, it appears that cessation of smoking is associated with 
improvement of endothelial function in human subjects.  Mechanisms that contribute to 
impaired endothelium-dependent relaxation of large blood vessels during cigarette 
smoking have been investigated.  Studies by Motoyama et al. (1997) and Heitzer et al. 
(1996) found that impaired endothelium-d pendent vasodilatation observed in chronic 
smokers could be restored by acute treatment with vitamin C, an antioxidant.  Thus it 
appears that oxygen radical formation plays an important role in impaired reactivity of 
large conduit vessels in chronic smokers (Ting et al., 1997).   
Studies using animal models have shown that smoking and the components of 
cigarette smoke impair endothelium-d pendent responses of blood vessels (Suzuki et al., 
1996a; Ota et al., 1997). Mechanisms that contribute to impaired endothelium- ependent 
reactivity of blood vessels after exposure to cigarette smoke also have been examined.  It 
has been found that cigarette smoke extract impairment of endothelium-dependent 
dilatation of cheek pouch arterioles could be restored by treatment with indomethacin, a 
cyclooxygenase inhibitor. These findings suggest that the mechanism of impaired 
responses of cheek pouch arterioles after exposure to cigarette smoke extract appears to 
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be related to the release of substances produced via the cyclooxygenase pathway 
(Rubinstein et al., 1991).  This was confirmed by Suzuki et al. (1996a) who found that 
smokeless tobacco (moist snuff) impaired endothelium-dependent dilatation of cheek 
pouch arterioles. Indomethacin and SQ-29548, a thromboxane A2/prostaglandin H2-
receptor antagonist, abrogated the attenuating effects of smokeless tobacco extract on 
acetylcholine- and bradykinin-induced vasodilation. These data indicate that an aqueous 
extract of smokeless tobacco impairs endothelium-dependent vasodilation in the oral 
mucosa in situ in a specific fashion and that these effects are mediated, in part, by 
cyclooxygenase products of arachidonic acid metabolism that stimulate romboxane 
A2/prostaglandin H2 receptors. Cigarette smoking is one of the risk factors for 
hypertension and stroke.  However, a consensus of the causal relationship between 
cardiovascular disorders and consumption of smokeless tobacco has not been reached 
yet.  What has been known is the acute hypertensive effect of smokeless tobacco on 
users (Westman 1995; Nowak, 1994). During smokeless tobacco use (5 to 30 min), 
systolic and diastolic blood pressure persistently increased.  This increase remained up 
to 90 min after smokeless tobacco use.  The potential long-t rm risk of using smokeless 
tobacco is obvious since smokeless tobacco induced transient hypertension may 
predispose smokeless tobacco users to myocardial infarction, hypertension, and stroke 
(Benowitz, 1993).  The most significant substance that raises blood pressure in 
smokeless tobacco is nicotine. Yet the vascular effects of nicotine and the underlying 
mechanisms are still to be clarified.  Nicotine, in smokeless tobacco, is absorbed rapidly 
through the oral mucosa in smokeless tobacco users. Absorb d nicotine releases 
catecholamine from sympathetic nerve endings.  The subsequent activation of a-
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adrenoceptors in vascular smooth muscle cells contracts vascular tissues and elevates 
blood pressure (Toda et al.,  1995). Nicotine also actsdirectly on vascular smooth 
muscle cells to induce vascular relaxation or contraction.  The direct effect of nicotine 
on vascular smooth muscle cells as well as the nicotine-induced adr nergic stimulation 
substantially contributes to altered cardiovascular function wi h smokeless tobacco 
consumption.        
 
1.4.2.  Nicotine and other alkaloids in various tobacco products 
Nicotine is a tertiary amine composed of a pyridine and a pyrrolidine ring (Fig. 
1.4). Nicotine may exist in two different three dimensionally structured shapes, called 
stereoisomers. Tobacco contains only (S)-nicotine (also called 1-nicotine), which is the 
most pharmacologically ctive form. Tobacco smoke also contains the less potent (R)-
nicotine (also called d-nicotine) in quantities up to 10 percent of the total nicotine 
present. Although the major alkaloid in tobacco is nicotine, there are other alkaloids in 
tobacco. These include nornicotine, anabasine, myosmine, nicotyrine, and anatabine. 
These substances make up 8 to 12 percent of the total alkaloid content of tobacco 
products.  
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Figure 1.4. Structure of nicotine. Nicotine is a tertiary amine composed of a pyridine 
and a pyrrolidine ring.    
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1.4.3.  Effect of nicotine on resistant arteriolar dilatation
In vivo, acute infusion of nicotine at low concentrations causes impairment of the 
endothelium-dependent dilatation of peripheral resistance arterioles contained within the 
microcirculation of the hamster cheek pouch (Mayhan and Patel 1997).  High 
concentrations of plasma nicotine (14 ng/ml), which is similar to that observed in 
smokers, produced a profound selective impairment of endothelium-dependent 
vasodilatation. 
The effect of nicotine on endothelium-d pendent vasodilatation is reversed by 
topical application of superoxide dismutase (SOD).  Therefore, it has been suggested 
that nicotine impairs endothelium-d pendent arteriolar dilatation via an increase in the 
synthesis/release of oxygen-derived free radicals (OFR) (Mayhan and Sharpe 1998).  
Cigarette smoke and products of cigarette smoke produce diffuse vascular injury in 
many organ systems and impair nitric oxide synthase-dependent dilatation of large 
peripheral arteries (Celermajer et al., 1993) and resistance arterioles (Rubinstein et al., 
1991).  Investigators have shown that nicotine has toxic effects on endothelium, and thus 
nicotine may play a key role in impaired nitric oxide synthase-depe dent vasoreactivity 
observed in users of tobacco. Nicotine produces morphological abnormalities of the 
endothelium causing direct alteration of the vascular reactivity. Heitzer et al. (1996) 
reported that treatment of smokers with vitamin C, an antioxidant, improved impaired 
endothelium-dependent reactivity of large and peripheral arteries (Fig. 1.5). In animals 
planted with nicotine containing pumps, it has been shown that plasma levels were 
strongly related to the dose of nicotine administered (0.18-4.7 mg/kg/day).  There was a 
strong positive correlation between plasma levels of nicotine and its major metabolite 
cotinine in nicotine treated rats.   It is probable that nicotine concentration in       
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Figure 1.5. Schematic diagram of oxidative stress in smoking leading to heart disease 
(Olinescu and Smith 2002).   
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habitual smokers is elevated throughout the course of the day.  In support of this, Isaac 
and Rand (1972) have shown that the plasma level of nicotine is 25 ± 6 ng/ml at 6.5 h 
after ad libitum smoking.  Furthermore, several previous studies have shown that plasma 
levels of nicotine are elevated in chronic smokers (Benowitz, 1993, Hirshkowitz et al., 
1992; Motoyama et al., 1997).  Thus, although many of the above studies examined the 
acute effects of nicotine infusion on arteriolar reactivity, it is believed that those studies 
have important implications for the chronic effects of cigarette smoking and the use of 
smokeless tobacco products on vascular reactivity because this might more accurately 
reflect what is found in chronic smokers.  And indeed, it has been shown that in 
hamsters chronically treated with nicotine (2 µg/kg/day) for 2-3 weeks, the resistance 
arterioles of the cheek pouch produces a selective impairment of endothelium-dep ent 
arteriolar dilatation via a mechanism related to the synthesis/release of OFR (Mayhan
and Sharpe, 1999).  The magnitude of the resistant arteriole vasodilatation in response to 
acetylcholine was significantly less in hamsters treated with nicotine than in control 
hamsters. Superfusion with SOD potentiates responses of the arterioles to acetylch line.  
Thus it appears that SOD, although it does not affect the baseline diameter of resistant 
arterioles, can prevent the impairment of endothelium-dependent arteriolar reactivity in 
hamsters treated with nicotine.  Although these previous studies pr vide insights into the 
mechanisms by which acute and chronic treatment of nicotine could alter the 
endothelium-dependent reactivity of resistance vessels, there are other studies that 
showed nicotine might not have altered acetylcholine-induced changes in perfusion 
pressure of isolated mesenteric circulation.  Li and colleagues (1994) examined the 
pressure drop across the isolated perfused mesenteric arteries in rats in response to 
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acetylcholine. These investigators found that chronic (2-weeks) treatment wi h nicotine 
did not alter acetylcholine-induced changes in perfusion pressure of isolated rat 
mesenteric circulation.   
 
1.4.4.  Nicotine and ion channels 
Nicotine is the main constituent of tobacco smoke responsible for the elevated 
risk of the cardiovascular disease and sudden coronary death associated with smoking, 
presumably by provoking cardiac arrhythmias. The cellular mechanisms may be related 
to the ability of nicotine to prolong action potentials and depolarize membrane potential. 
However, the underlying ionic mechanisms remained unknown. Wang and colleagues 
(2000a) demonstrated that nicotine blocked multiple types of K+ curr nts (including A-
type currents, delayed rectifier current and inward rectifier current) with preferential 
inhibition of transient outward currents Ito/Kv4.3. Those results indicate that nicotine is a 
non-specific blocker of K+ channels with certain selectivity toward A-type currents. The 
effects of nicotine were independent of nicotine receptor stimulation or catecholamine 
release since the effects were not reversed or prevented by mecamylamine (100 mM, 
nicotine receptor antagonist), atropine (1 mM, muscarinic receptor antagonist), or 
propranolol (2 mM, non-selective b-adrenoceptor blocker). Thus the inhibitory effects 
are likely the consequence of direct interactions between nicotine molecules and the 
channel protein. Reports on the effect of nicoti e on ion channels are not conclusive. 
Wang et al. (2000a) provided insight into potential mechanisms underlying nicotine 
block of A-type currents. Approximately 40% of the total inhibition could be ascribed to 
tonic block, with the remainder (60%) due to use-d pendent block, for both Kv4.3 and 
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Ito. This would imply that nicotine binds to transient outward K+ current (Ito) channels in 
the closed state.  
The cardiac effects of nicotine have been ascribed to enhanced release of 
catecholamines. However, accumulating evidence has shown that nicotine can also exert 
its effects without involvement of nAChRs and catecholamine release. Studies under 
conditions devoid of nAChR stimulation demonstrated the ability of nicotine to alter 
action potential (AP) characteristics in guinea pigs (Pappano and Rembish 1970), rabbits 
(Carryl et al., 1992), and dogs (Greenspan et al., 1969) in different tissues such as inus 
nodes (Satoh, 1997), atrium, ventricle, and Purkinje fibers. The most noticeable changes 
were decreases in resting potential and prolongation of later AP phases. It is therefore 
quite conceivable that nicotine might be able to interact directly with ion channels. 
Hamon et al. (1997) first reported that nicotine inhibited slowly inactivating K+ currents 
in rat cultured striatal neurons. The effects were attributed to stimulation of nicotine 
receptors, because the nicotinic antagonist dihydro-b-erythroidine reversed and nicotinic 
agonists reproduced the block. Direct effects on K+ chan els were not revealed until 
recently by our laboratory (Tang et al., 1999) in experiments that used vascular smooth 
muscle cells. Tang et al. (1999) demonstrated hat nicotine caused dual effects on the 
rapidly activating and slowly inactivating K+ currents in rat artery smooth muscle cells, 
an increase in current amplitude at concentrations < 0.3 mmol/L and a decrease at > 0.3 
mmol/L.  
It has been suggested that Kv4.3 and Kv4.2 are the major molecular constituents 
of native cardiac Ito. The ability of nicotine to block Kv4.3 and Kv4.2 might contribute 
to the previously observed lengthening of cardiac action potential duration in many 
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preparations (Pappano d Rembish, 1970; Carryl et al., 1992). Nicotine preferentially 
prolongs initial repolarization and the subsequent plateau phases, consistent with the 
participation of Ito in early phases of repolarization. A-type K+ channels are not limited 
to cardiac cells. Both cloned and native A-type currents have been identified in a variety 
of tissues, including brain and vascular smooth muscle. The A-type K+ current in 
vascular smooth muscle is believed to act as a “break” to counteract depolarizing 
influences that may induce spontaneous action potential activity or oscillatory 
vasoconstriction. Nicotine is known to have vasoconstriction properties that contribute 
to the elevation of blood pressure and stroke risks induced by this compound. Nicotine is 
one of the most potent blockers of A-type channels. 4-aminopyridine (4-AP) is in 
widespread use as a pharmacological tool for its ability to inhibit A-type K+ current 
selectively. However, as documented in many previous reports, several hundred 
micromolar to several millimolar c ncentrations of 4-AP are necessary to block Kv4.3 
and Ito. The potency of nicotine to block Kv4.3 was ~ 4x104 –fold higher than that of 4-
AP (IC50 = 40 ± 4 nM for nicotine versus 1.7 ± 0 2 mM for 4-AP). Thus, nicotine can be 
potentially a useful pharmacological probe to study the role of A-type channels in 
cardiac electrical activity and the outcome of pharmacological interventions on A-type 
channels.  
Decreases in inward rectifier K+ currents (Kir) have been implicated in a variety 
of disease states of the heart, including myocardial infarction and ischemia, cardiac 
hypertrophy, and heart failure (Beuckelmann et al., 1993). This decrease is often 
accompanied by cell membrane hyperpolarization and generation of arrhythmias, such 
as ectopic beats, early fterdepolarization, and triggered activity (Wilde and Aksnes, 
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1995). A recent work aimed at elucidating the factors involved in action potential 
initiation in rabbit heart revealed that Kir is a major determinant (Golod et al., 1998). 
Depression of Kir can lead to increased susceptibility to activation of cells from an 
ectopic focus, due to increased input impedance and reduced current threshold. Wang et 
al. (2000a) reported that nicotine could block inward rectifier K+ chann ls. It is not 
unreasonable to speculate that nicotine could worsen the heart diseases by promoting 
arrhythmias in part by directly blocking cardiac Kir. Simard and Li (2000) demonstrated 
that nicotine exposure caused a decrease in bioavailability of endogenous NO, as well as 
block of endogenous NOS activity and oxidative endothelial injury, resulting in a 
significant increase in Ca2+ channel availability. Nicotine increased availability of Ca2+ 
channels and decreased availability of KCa channels in cerebral arterioles (Gerzanich et 
al., 2001). Nicotine altered NO signaling of L-type Ca2+ channels by a mechanism 
undescribed, causing blockage of the downregulation of Ca2+ channels by NO and 
cGMP without altering normal upregulation of Ca2+ -activ ted K+ channels by NO and 
cGMP.  Moreover, Gerzanich et al. (2001) reported the significance of these ion 
channels by showing reduced pial vasorelaxation in response to NO in animals 
chronically exposed to nicotine.  
In guinea pig ventricular cardiomyocytes, nicotine (100 a d 30 µM) has been 
shown to inhibit Ca2+ and Kv channels (Satoh, 2002). At 1 mM, nicotine blocked Ca2+ 
currents by approximately 90%. The responses to nicotine were not significantly 
modified by atropine (muscarinic receptor antagonist), hexamethonium (ganglion 
blocker), and nicot ne receptor antagonists (d- ubocurarine and benzoquinonium). 
Nicotine also strongly inhibited the Kir channels in these cells. The cardiac actions 
induced by nicotine results from the modulation of ion channels across the cell 
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membrane. The Kir possessed higher sensitivity to nicotine than Ca2+ and Kv channels. 
In rabbit SA nodal cells with no existence of Kir, nicotine inhibited Ca2+ channels but 
had less or no effect on Kv (Damaj et al., 1993). The Kir mostly contributes to the 
resting potential, and the Kir inhibition might be expected to lead to partial 
depolarization of the membrane. However, nicotine did not affect the resting potential in 
guinea pig ventricular muscles and rabbit SA cells (Satoh, 1997).  
 
1.4.5. Nicotinic acetylcholine receptors 
The nicotinic acetylcholine receptor (nAChR) is a ligand-gated channel that 
delineates a cation-selective pathway across the plasma membrane (Miyaz wa et al., 
2003). Comprising pentameric combinations of homologous, genetically distinct 
subunits, nACh receptors are formed from a portfolio of á– and â-subunits (á2– á10 and 
â2– â4), the differential association of which confers distinct functional and structural 
properties to the resultant subtypes of nACh receptor (Fenster et al., 1997). nACh 
receptors mediate fast synaptic transmission in ganglion c neurons. However, there are 
only a few examples of this in the mammalian CNS (Frazier et al., 1998) where nACh 
receptors exert a more modulatory influence. In addition to rapid changes in membrane 
potential, activation of ligand- ted ion channels can also generate longer-lasting effects 
in the receptive neuron, which contribute to the elaboration of complex intracellular 
signals that mediate medium- to long-term events. In particular, the role played by 
intracellular Ca2+ signals in the survival of developing neurons, the modulation of their 
activity and, ultimately, their demise, places Ca2+-perme ble nACh receptors in a pivotal 
position for regulating such events (Role et al., 1996). The structure of the nAChR 
agonists binding sites has been the subject of intense investigation for more than 20 
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years. Functional and biochemical data indicate that there are two binding sites for ACh 
located within the á2âäã oligomeric structure of the receptor found in embryonic 
muscle, and early affinity labeling studies and mutagensis experiments provided strong 
evidence that the á subunits play a major role in ligand binding. 
Two different types of nicotinic acetylcholine receptors (nAChRs) are 
distinguished: First, themuscle type confers synaptic transmission at the motor endplate. 
Second, the neuronal type was originally discovered in the nervous system, but is also 
expressed in a variety of non-neuronal cells, forexample keratinocytes (Grando et al., 
1995), bronchial epithelial cells (Conti-Fine et al., 2000) and the epithelium of the 
gastrointestinal tract (Wessler et al., 1998). In these tissues nAChRs participate in the 
regulation of a broad spectrum of cellular functions, for example ciliary motility, 
formation and maintenance of cell-cell contacts, resorption and secretion (Wessler et al., 
1998). 
In view of the profound pathogenic effects of chronic nicotine exposure on 
vascular wall structure, the presence of nAChRs shall be expected in the vascular wall. 
Their occurrence on nerve fibres innervating blood vessels is well established. 
Prejunctional nAChRs on sympathetic axons inhibit noradrenaline release (Edvinsson et 
al., 1977), and stimulation of nAChRs located n nitrergic parasympathetic axons leads 
to release of NO with subsequent vasodilatation (Ayajiki et al., 1994). There is, 
however, growing evidence for an additional non-neuro al localisation of nAChRs in 
the arterial wall. Nicotine induces vasoconstriction in the denervated pulmonary 
circulation in the dog (Samanèk and Aviado 1966), it relaxes the isolated rat renal artery 
(Emre et al., 1999) and it impairs endothelial- ependent relaxation in the hamster cheek 
pouch (Mayhan and Patel 1997). In humans, Stefanadis et al. (1997) showed an 
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ultrasonically measurable decrease of aortic elasticity while patients were smoking. 
Primary cell cultures of arterial endothelial cells (ECs) express functional nAChRs 
(Conti-Fine et al., 2000; Wang et al., 2001), and in vivo ligand binding studies showed 
specific binding sites for [3H]-nicotine in human cerebral and pial vessels (Kalaria et al. 
1994). An immunohistochemical study of the fetal monkey lung localised the á7-subunit 
to the arterial wall (Sekhon et al., 1999), but data on the detailed distribution of the 
individual nAChR subunits in the arterial wall and arterial system, however, are still 
lacking. 
Brüggmann and colleagues (2002) reported that nAChR subtypes are expressed 
by both ECs and vascular SMCs in rat arteries in situ. Consequently, these main cellular 
components of the vasculr wall shall be considered as direct targets of nicotine and 
endogenous nAChR ligands such as acetylcholine. The large conductive arteries 
investigated in that study are devoid of a cholinergic innervation, so that an endogenous 
ligand addressing their nAChRs will not be derived from a neuronal source. Instead, ECs 
have been recognized as a major source of ACh. They express the acetylcholine-
synthesizing enzyme, choline acetyltransferase, and they synthesize and release ACh 
(Haberberger et al., 2000; Kawashima et al., 1990). Thus, there is evidence for a locally 
acting autocrine and paracrine non-neur al cholinergic system in the arterial wall 
(Kummer and Haberberger 1999) that includes nAChRs. Well in line with this notion, a 
nicotinic angiogenic pathway as recently been described that operates both in situin a 
disc angiogenesis system and in vivo in plaque formation during atherosclerosis, tumour 
growth and wound healing (Heeschen et al., 2001). This system acts endogenously since 
angiogenesis in a murine hind limb ischaemia model is significantly reduced by the non-
selective nAChR antagonists, mecamylamine (Heeschen et al., 2002). 
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Vascular SMCs cultured from the rat tail artery are likely to express functional 
nAChRs since they respond to nicotine with a membrane depolarisation and altered K+ 
currents (Tang et al., 1999; Wang and Wang 2000). The subunits involved in these 
effects have not been identified. Brüggmann and colleagues (2002) identified á3-, á5-, 
á7- and á10-subunits in vascular SMCs while the dis ribution of the subunits á2, á4 and 
á6 was more selective. The subunit á2 was detected in proximal elastic arteries, while 
á4 and á6 occurred only distal to the ascending aorta. The parallel occurrence of á4 and 
á6 is consistent with the observation that á4, á 6 and â2 are able to build up a functional 
nicotinic receptor (Kuryatov et al., 2000). 
The occurrence of the á10-subunit in vascular SMCs without the simultaneous 
expression of the á9-subunit is noteworthy because á9 is its only known interacting 
partner to form a functional nAChR (Elgoyhen et al.,2001). Accordingly, cell types 
expressing the á10-subunit have so far always been found to coexpress the á9-subunit 
(Elgoyhen et al., 2001). While coexpression studies of subunits â2, â4, and á2 to á6 with 
á10 have been conducted and did not result in a functional receptor, the properties of an 
á7/á10 combination have not been reported yet (Elgoyhen et al., 2001). The extensive 
codistribution of á7- and á10-subunits in vascular SMCs of rat arteries may be taken as 
a hint to a functional coupling of these subunits. 
A striking feature of the distribution pattern of nAChRs in the rat arterial system 
is its extensive heterogeneity. While every á-subunit except á9 was detected in the 
thoracic aorta, intrapulmonary arterial branches contained only á7 immunoreactivity, 
and other vascular beds held intermediate positions with respect to the extent of á-
subunit expression. Current knowledge does not allow correlating these distribution 
patterns to specific functions, but it can be anticipated that at least some components of 
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nAChR-mediated signaling in the arterial wall are highly specific for individual arteries. 
One of the implications derived from this may be different vulnerabilities of individual 
arterial beds to externally applied nicotine. 
 
1.5. OXYGEN FREE RADICALS  
 
1.5.1.  Definition of oxygen free radicals 
Oxygen free radicals have been implicated in the pathophysiology of various 
disease processes including ischemia-reperfusion injury, heart failure, 
hypercholesteremic atherosclerosis, diabetes mellitus, hemorrhagic and endotoxic shock, 
and peripheral vascular disease (Hogg 1998; Bergamini et al., 2004). Free radicals are 
defined as molecules that contain an unpaired electron. Organic molecules normally 
possess an even number of electrons with each orbital being occupied by two electrons 
having an opposite magnetic moment and spin. Consequently, free radicals poss ss such 
a great chemical reactivity that rate constants can reach the limit for free diffusion 
(109M-1s-1). Generally, the simpler the structure, the shorter the life of free radicals. 
Complex molecules, like triphenylmethyl, have more stability and a longer life span. 
This means that, in effect, these reactions proceed nearly instantaneously.  
It is interesting to note that much of the recent research into free radical reactions 
is a consequence of the Cold War (Olinescu and Smith, 2002).  Following the invention 
of nuclear weapons in the Second World War, there was a great deal of interest in 
radiation disease. The discovery that free radicals are involved in the first steps of the 
consequences of irradiation of living organisms attracted much attention to the field of 
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free radical research. Likewise, the interest in free radicals by physician and medical 
researchers is based on their role in physiology and pathophysiology. 
  
1.5.2.  Generation of oxygen free radicals 
Oxygen-derived free radicals include the superoxide anion (O2.-), and hydroxyl 
(.OH), peroxyl (ROO.), alkoxyl (RO.), and hydroxyperoxyl (HOO.) radicals. Oxygen 
metabolites that contain an even number of electrons, such as H2O2 and hypochlorous 
acid (HOCl), are not oxygen-derived free radicals (Bergamini et al., 2004). 
 
1.5.2.1. Superoxide anion (O2.-) 
  Univalent reduction of molecular oxygen generates O2.- , which is very unstable. 
It can act as both oxidant and reductant (Wu et al., 2001). It oxidizes ascorbate, 
sulfhydryl-containing compounds, sulfate, and catecholamines. It reduces ferric iron and 
quinines. It inactivates a variety of nzymes (e.g., tRNAase, RNAase, glyceraldehydes-
3-phosphatedehydrogenase, and aconitase). O2.- is not highly toxic, and most of the 
damaging effects are due to highly toxic .OH. Oxygen is metabolized as shown in Fig. 
1.6. The sequential transfer of one electron to oxygen (i.e. the sequential reduction of 
oxygen) results in the formation of two intermediates (less reactive O2.- and h ghly 
reactive hydroxyl radical OH.),  a relatively stable and long-lived intermediate 
(hydrogen peroxide, H2O2), and a stable and harmless end product (water). 
  O2 + 1e-          O2.-    +1e- +  2H+    H2O2       + 1e-       OH.      +1 e- + 2H+ H2O 
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Singlet oxygen                  SOD   Catalase or GSH-Px 
 
          
Oxygen Superoxide anion           Hydrogen peroxide      H2O + O2 
(O2)     (O2.-)       (H2O2) 
     
              
Hydroxyl radical (OH.) 
 
 
Figure 1.6. Schematic diagram of oxygen free radicals generation. SOD indicates 
superoxide dismutase; GSH-Px, glutathione peroxidase (Prasad, 2000).  
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1.5.2.2. Hydrogen Peroxide (H2O2) 
H2O2 is formed by dismutation of O2.- , a process accelerated by SOD (Bergamini 
et al., 2004). It is a relatively stable oxidant and very lipophilic and hence crosses cell 
membranes rapidly. It can inactivate some enzymes by oxidizing their reactive 
sulfhydryl groups. Catalase and glutathione peroxidase (GSH-Px) convert it to H2O + 
O2.   
 
1.5.2.3. Hydroxyl radical (OH.)  
Hydroxyl radical is generated in two reactions. 
Fenton reaction: Fe2+ + H2O2   Fe3+ + OH. + OH- 
Haber-Weiss reaction: H2O2 + O2.-  Fe3+/Fe2+  OH. + O2 + H2O 
A two-step reaction is involved in Haber-Weiss reaction, in which OH. is formed in a 
traditional Fenton reaction followed by reduction of the iron by superoxide anion (Fe3+ + 
O2.-   Fe2+ + O2). In this sequence, recycling of the metal catalyst maintains a 
reaction chain.      
 
1.5.2.4. Alkoxyl radicals (OR.) and peroxyl radicals (OOR.) 
Lipid peroxidation generates two additional reactive and short-lived radicals, 
namely, alkoxyl radicals (OR.) and peroxyl radicals (OOR.). In addition, organic 
peroxides (lipid hydroperoxides, ROOH) are also formed as relatively more-stable 
intermediates or end products. 
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1.5.2.5. Nitric oxide (NO.) 
NO. is also an ROS because it has an unpaired electron associated with the 
oxygen atom. An interaction of NO.  with superoxide anion produces a labile non-radical 
compound, the peroxynitrite anion (O2.- + N .  ONOO-). When peroxynitrous acid 
is formed by acidification of the anion (ONOO- + H+   ONOOH), it will 
spontaneously decompose by homolytic scission to yield the highly reactive hydroxyl 
radical (ONOOH   OH. + ONO.).      
 
1.5.2.6. Oxidized glutathione (GSSG) 
GSSG, a disulfide-linked homodimer, is known for its action to oxidize protein 
thiols. Either an intramolecular disulfide bond between adjacent sulfhydryls in the 
protein or a mixed disulfide bond between the protein and glutathio e will be formed as 
the result of the GSSG-induced oxidation. Being generated via the action of glutathione 
peroxidase (GSH-Px), GSSG is reduced back to glutathione (GSH) via the activity of 
GSH reductase (GSH-Rt), which serves to maintain GSSGlevels between one-tenth and 
one hundredth those of total GSH. GSH, a tripeptide, is the single most abu dant redox-
active sulfhydryl compound within the cytosol of mammalian cells. By providing 
reducing equivalents for the redox reaction catalyzed by GSH peroxidase, GSH 
represents the major antioxidant defense m chanism.       
 
1.5.3. Sources of oxygen free radicals 
Normal cellular energy metabolism is not 100% efficient, and it is considered 
that between 1% and 5% of all oxygen atoms used in energy metabolism escapes as 
oxygen free radicals. Oxidative reactions are also very important in other biological 
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reactions and many of these have the potential to g erate oxygen free radicals under 
physiological conditions. For example, both cytochrome P450s and cyclooxygenase 
generate oxygen free radicals. Thus, the production of oxygen free radicals can be a 
natural part of cellular function. Two main endoge ous O2.- generating enzyme systems 
are xanthine oxidase (XO) and NADH/NADPH oxidase. In vivo, xanthine 
dehydrogenase is converted to XO which mediates the metabolism of nucleotides such 
as xanthine and hypoxanthine (HX) to form O2.-, H2O2, and uric acid (Fig. 1.7). 
Inhibitors of XO, e.g. allopurinol and oxypurinol, have been used to attenuate the injury 
process and have permitted the identification of XO as a mediator of tissue injury. 
NADH/NADPH oxidase is a multi-subunit enzyme, which has been claimed to be the 
major source of O2.- production in many tissues.       
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Figure 1.7. Schematic diagram for the formation of oxygen radicals with interaction 
of an adenine nucleotide and xanthine oxidase. ATP indicates adenosin  triphosphate, 
AMP, adenosine monophsophate (Prasad, 2000).    
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1.5.4.  Antioxidants 
Antioxidants, when present at a low concentration compared with the 
concentration of an oxidizable substrate, significantly delay or inhibit oxidation of that 
substrate. The body is equipped with a variety of antioxidants to protect against 
excessive radical generation and the consequences thereof. Intracellular antioxidants 
scavenge aberrant free radicals locally. Extracellular antioxidants break the chain of 
radical reaction propagation and remove metal ions and heme proteins by sequestering 
them and making them incapable of generating free radicals. There are two classes of 
antioxidants: enzymatic and nonenzymatic, wh h includes exogenous and endogenous 
substances. Enzymatic antioxidants include: SOD, catalase, GSH-Px, and other 
peroxidases. Nonenzymatic antioxidants include those that are water soluble (vitamin C, 
uric acid, glucose, pyruvate, bilirubin, and sulfhydryl groups), li id soluble (alpha 
tocopherol, beta carotene, ubiquinol 10), and plasma protein-bound (transferrin, 
albumin, ceruloplasmin, haptoglobin, and hemopexin molecules). 
Antioxidants are substances that donate an electron to a free radical thus 
inactivating the radical species. Some of theseantioxidants exist in several forms. 
Membrane, cytosolic and plasma isoforms of GSH-Px have been reported. Similarly, 
there are mitochondrial, cytosolic, and extracellular isoforms of SOD. The vast network 
of intracellular and extracellular antioxidants strongly uggests that the levels of 
endogenous antioxidants must be tightly regulated for cell survival.     
 
 
                                  
  42 
1.6. ACETYLCHOLINE ( ACh) 
 
1.6.1. Acetylcholine and neurotransmission 
ACh is best known as a neurotransmitter. However, ACh probably evolved long 
before the appearance of the nervous system, since the machinery to synthesize and 
degrade ACh is present in bacteria, fungi, protozoa and plants. Even in so-called higher 
organisms, ACh is present in nonneuronal tissues such as the placenta, suggesting that 
ACh has cellular functions other than neurotransmission. 
As a neurotransmitter, ACh was among the first to be identified. ACh was 
identified as a possible mediator of cellular function by Hunt in 1907. In the 1910s, it 
was shown by Sir Henry Dale to mimic the effect of parasympathetic nerve stimulation 
and to have different actions depending on the tissue. The latter observation suggested 
the presence of separate ‘receptive substances’. ACh rel ase upon nerve stimulation was 
demonstrated in the 1920s by Otto Loewi, in elegantly simple experiments using two 
frog hearts. Despite this impressive beginning, a definitive mapping of central 
cholinergic pathways was not available until the 1960s, when Shute and Lewis published 
a series of studies using acetylcholinesterase (AChE), providing the first overall picture 
of cholinergic pathways (Lewis and Shute, 1967; Shute and L wis, 1967). However, the 
results of these landmark studies remained somewhat tentative, because AChE is present 
not only in cholinergic neurons, but also in noncholinergic neurons such as certain 
noradrenergic and dopaminergic neurons. In the early 1980s, ntibodies to choline 
acetyltransferase (ChAT), the biosynthetic enzyme for ACh, became available (Kimura 
et al., 1981; Crawford et al., 1982) and these antibodies made it possible, for the first 
time, to identify cholinergic pathways definitively.           
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The role of ACh as a key neurotransmitter in the central and peripheral nervous 
system is well established. However, the role of ACh may be broader because ACh may 
also function as an autocrine or paracrine signaling molecule in a variety of nonneuronal 
tissues (Wessler et al., 1998). ACh is the first neurotransmitter whose diffusion from the 
central nervous system was investigated and whose extracellular level variations were 
correlated to changes in neuronal activity. This was done initially by means of the cup 
technique and then by the microdialysis technique (Metzen et al., 2003). The latter, 
notwithstanding some technical limitations, makes it possible to detect variations in 
extracellular levels of ACh in unrestrained, behaving animals. Investigations had shown 
that there are changes in ACh release during performance of operant tasks, exposure to 
novel stimuli, locomotor activity, and the performance of spatial memory tasks, working 
memory, and place preference memory tasks. Activation of the forebrain cholinergic 
system has been demonstrated in many tasks and conditions in which the e vironment 
requires the animal to analyze novel stimuli that may represent a threat or offer a reward. 
The sustained cholinergic activation, demonstrated by high levels of extracellular ACh 
observed during the behavioral paradigms, indicates that many be viors occur within or 
require the facilitation provided by the cholinergic system to the operation of pertinent 
neuronal pathways (Wessler et al., 1999).  
 
1.6.2.  The non-neuronal cholinergic system in the endothelium 
It is becoming increasingly apparent that ACh is not used exclusively by the 
nervous system. Thus the non-neuronal ACh has been found not only in the major 
classes of the animal kingdom, but also in primitive plants. This has led to the concept of 
“non-neuronal cholinergic system” (Wessler et al., 1999), the essential elem nts of 
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which have been demonstrated in various human tissues, including immunocompetent 
cells such as lymphocytes, respiratory epithelial cells and keratinocytes. It is well known 
that ACh mediates multiple effects on the vascular endothelium, for example the
generation of the endothelium-derived relaxing factor (EDRF) (Furchgott and Zawadzki, 
1980). Therefore it appears of great biological interest whether endothelial cells are 
endowed with the biochemical apparatus to synthesize, transport, store and secrete ACh 
by themselves to control endothelial cell functions by local regulatory loops. P rnavelas 
and co-workers (1985) used ultrastructural immunocytochemistry to localize the 
synthesizing enzyme ChAT in endothelial cells of rat brain capillaries. These authors 
suggested that the release of ACh from endothelial cells as a result of ischemic damage 
could be protective against further hypoxia via the vasodilatory activity of ACh. 
Following isolation of rat brain cortex capillaries, a ChAT specific activity of 0.264 
nmol/mg protein/min in the dissociated endothelial cells has been reported (Gonzalez 
and Santos-Benito, 1987). However, in human fetal brain microvessels in culture, other 
authors failed to detect ChAT activity (Kasa et al., 1991). A very significant finding was 
provided by Kawashima and colleagues (1990), who studied ACh synthesis and release 
in bovine carotid artery endothelial cells in vitro. Analytical measurement by 
radioimmunoassay and HPLC indicated that the endothelial cells synthesize ACh a d 
that the synthesized ACh was rapidly released from the cells (Kawashima et al., 1990). 
In endothelial cells isolated from porcine cerebral microvessels, both HPLC and 
radioimmunoassay methods were used to measure ACh cont nt (Ikeda et al., 1994). 
Phorbol ester was found to up-regulate ACh synthesis via a protein kinase C-
independent pathway (Ikeda et al., 1994). However, studies with the ChAT inhibitor, 
bromoacetylcholine, suggested that ACh synthesis occurred independently of ChAT; 
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i.e., an enzyme different from ChAT mediated the synthesis of ACh. Further studies by 
the same group investigated choline uptake in porcine brain endothelial cells and its 
utilization for both phospholipid and ACh synthesis (Suzuki et al., 1996b). Recently, an 
immortalized rat brain endothelial cells (RBE4) havebeen used to engineer stable 
endothelial cell lines producing ACh (Malo et al., 1999). This has been achieved by 
employing an expression vector construct to transfect ChAT. Further studies have been 
carried out on endothelial cells transfected with the vesicular ACh tr nsporter (VAChT) 
gene. It is to be expected that such genetically modified endothelial cell types may help 
unravel some of the regulatory pathways involved in ACh synthesis, storage, transport 
and release. The ability of the endothelium to respond to ACh has been well 
documented. This response depends on the expression of ACh receptors (AChR), which 
are of either muscarinic (mAChR) or nicotinic (nAChR) type. The pioneering work of 
Furchgott and Zawadzki (Furchgott and Zawadzki, 1980) demonstrated that following 
interaction of ACh and mAChR, the endothelium produced a vasodilator, EDRF, now 
accepted as nitric oxide. Utilizing an i  situ hybridization technique, it was demonstrated 
previously that cultured en othelial cells from the human aorta express nAChR of the 
a3, a5, b2 and b4 subtypes (Macklin et al., 1998). Patch clamp experiments confirmed 
the functionality of these receptors. On the endothelium of human pulmonary veins, M1 
muscarinic receptors have been demonstrated (Walch et al., 2000). Offner and 
colleagues’ (1992) work has been focused on the use of human endothelial cell culture 
systems to investigate the pathobiology of the endothelium in various disease states with 
special emphasis on inflammation, sepsis and tumor extravasation. Using monolayer 
cultures of human umbilical vein endothelial cells, HPLC techniques were used to 
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demonstrate the production of ACh and a closely related compound. Similar results were 
found from a human angiosarcoma cell line. The non-neuronal cholinergic system in the 
endothelium represents the standing at the beginning of this fascinating chapter. There 
are many unanswered questions. One of the important tasks is to further define the 
subcellular localization of the synthesizing enzyme ChAT, as well as the vesicular 
transporter VAChT. The indications from the immunoelectr n microscopic study that 
VAChT can be detected in vesicles of the endothelial cytoplasm and the cytoskeletal-
like distribution demonstrated by light microscopic immunochemistry requires further 
investigation. The central question in this field of research must however remain the 
delineation of the functional significance of endogenous endothelial ACh. Thus, the 
possible role in endothelial cytokine expression, induction and regulation of cell 
adhesion molecules, proliferation, angiogensis and hemostatic control should be 
advanced during the next years.          
 
1.6.3. Acetylcholine and ion channels 
ACh is well known as a key-n urotransmitter of the parasympathetic nervous 
system.  To understand its role it is better to study the heart as an example of ACh effect. 
Autonomic regulation of the heart is effected mainly by two systems: the sympathetic 
and parasympathetic nervous systems. In the resting heart, the major influence is 
parasympathetic, whereas during exercise the situation is reversed and sympathetic 
stimulation becomes predominant. The sympathetic and parasympathetic subdivisions of 
the autonomic nervous system can be viewed, in general terms, as opposing each other 
(Yin-Yang) (Fig. 1.8). For example, sympathetic stimulation increases heart rate, blood 
pressure, and myocardial contractility, whereas parasympathetic stimulation slows the 
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Figure 1.8. Extrinsic regulation of the heart.     
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heart, decreases blood pressure, and causes a mark d negative inotropic effect on the 
atria (Loffelholz and Pappano, 1985). Until recently, it was generally taught that the 
ventricles were insensitive to both parasympathetic stimulation and ACh; however, it is 
now apparent that cholinergic nerves supply the ventricles and conducting tisues of the 
His-Purkinje system. The inhibitory effects of cholinergic stimulation on the ventricles 
and His-Purkinje system are much more prominent following b-adre ergic receptor 
stimulation, so that parasympathetic stimulation blunts the response to sympathetic 
stimulation. There are two important types of parasympathetic (cholinergic) receptors: 
the nicotinic receptors, which are found mainly in skeletal muscle and ganglial cells, and 
the muscarinic receptors. Muscarinic receptors are encoded by a number of different 
genes; most important are the M1-subtype, found mainly in autonomic ganglia and the 
central nervous system, the M2-subtype in the heart, and the M3-subtype in smooth 
muscle and secretory cells.All are blocked by atropine.    
Many clinical examples of sinus bradycardia result from excessive 
parasympathetic (vagal) tone, especially in younger patients. Chronic slowing of the 
sinus pacemaker is regularly seen in “athlete’s heart,” whereas sudden sinus bradycardia 
can occur abruptly in vasovagal syncope, the old-fas ione  “swoon”. Parasympathetic 
slowing of the sinus pacemaker is mediated by changes in at least three different ion 
channels (Pappano and Mubagwa, 1991); these changes are initiated when acetylcholin  
binds to cardiac M2 muscarinic receptors (Fig. 1.9). When ACh binds to the muscarinic 
receptors it causes conformational changes of those receptor  causing them to bind to the 
G proteins in the plasma membrane. The G proteins are heterotrimers made up of th ee 
subunits: Ga, Gb, and Gg. The larger Ga subunits are the major participants in the 
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Figure 1.9. Schematic diagram of ACh binding to cardiac M2 muscarinic receptors.   
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function of the G proteins; they are also largely responsible for the specificity of the G 
proteins. Interaction of Gi-GDP and promotion of GDP-GT  exchange on a unit of the 
Gi protein follows. Interaction between ai-GTP and adenylyl cyclase results in an 
inhibition of adenylyl cyclase. Inhibition of the adenylyl cyclase causes decrease of the 
cyclic-AMP levels and therefore, decreases of the heart rate and the inotropic activity of 
the heart.  
The first mechanism by which ACh and other muscarinic agonists cause sinus 
bradycardia is by hyperpolarizing the SA node, which occurs when either AC  or 
adenosine activates ACh-activated potassium current (Ik.ACh) in the SA node (Fig. 1.10). 
The effects of M2 receptors on Ik.ACh appear to be mediated by an inhibitory Gi that can 
be activated when ACh binds to its receptor. The ligand-receptor complex, by activ ting 
this G-protein, opens channels that carry the potassium current Ik.ACh. This brings resting 
potential closer to the Nernst potential for potassium. The ability of Ik.ACh to 
hyperpolarize the resting cell reflects the fact that the diastolic potentials in the SA node 
are considerably lower than equilibrium potential for K+ (EK). Ik.ACh is a G-protein-gated 
inwardly rectifying K+ channel (GIRK). The GIRK channel class comprises four 
members: GIRK1, GIRK2, GIRK3 and GIRK4. The cardiac Ik.ACh is a heterotetramer 
consisting of two GIRK1 and two GIRK4 subunits.  
The second ion channel that slows the SA node in response to ACh carries the 
inward pacemaker current, funny current (I¦). This pacemaker current is inhibited by a 
direct effect of Gi and an indirect effect that occurs when Gi inhibits cyclic AMP (c-
AMP) production. The decrease in cAMP concentrations also attenuates the calcium   
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Figure 1.10. Overview of the main ion channels in the heart affected by stimulation of 
muscarinic receptors at physiological concentrations. Abbreviations: I¦, pacemaker 
current; Ik.ACh, ACh-sensitive K+ current; IGJ, gap junctional current; M, Muscarinic 
receptor; b, b-adrenoceptor; AC, adenylyl cyclase; PDE, phosphodiesterase; PKG, 
cGMP-dependent protein kinase; PKA, cAMP-dependent protein kinase.    
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current ICa by reducing the probability of calcium channel opening. The resulting 
inhibition of ICa by reducing the major inward current that depolarizes the SA node also 
contributes to the SA block sometimes caused by vagal stimulation. 
If ACh is applied to atrial, Purkinje or nodal cells, hyperpolarization of the 
membrane typically occurs, which has been ascribed to the opening of Ik.ACh. The effects 
of mAChR receptor stimulation on Ik.ACh are transduced via the pertussis-toxin-sensitive 
Gi protein (Sakmann et al., 1983). For this action Mg2+ and GTP are required (Kurachi 
et al., 1986a; Kurachi et al., 1986b). The effect of muscarinic agonists can be mimicked 
with stable GTP analogues. If the cells are exposed to sufficient concentrations of 
muscarinic agonists continuously, a decrease in the current response has been detected 
without a change in the s ape of the current-vol age relationship (Carmeliet and 
Mubagwa, 1986). 
The opening of Ik.ACh in pacemaker cells starts with a latency of 30 to 100 ms
(Hartzell, 1980), which is longer than that for ligand-gated ion channels, but is 
considerably faster than that of second-messenger-regulated systems such as the b-
adrenoceptor-cAMP-ICa system (Yatani and Brown, 1989). In order to elucidate the 
underlying mechanisms, Soejima and Noma (1984) c rried out a series of very elegant 
patch-clamp experiments on rabbit trial cells: an on-cell patch in the absence of ACh 
revealed occasional opening of K+ channel that was not altered if ACh was added to the 
bath solution. However, when ACh was perfused into the pipette, the authors observed a 
dramatic increase in the opening of Ik.ACh. These experiments were consistent with the 
view that the channel and receptor are located in close proximity in the patch.  In 
contrast, a second-messenger ion channel system (such as b-adrenoceptor-cAMP-ICa 
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system) would (due to the diffusib lity of the second messenger) respond to the addition 
of the agonist to the bath in an on-cell patch situation with channel openings throughout 
the cell. Using excised patch experiments it has been shown that the exposure of the 
inner face of the membrane to previously activated Gi protein results in opening of Ik.ACh 
(Yatani et al., 1988). From the above experiments it was concluded that Ik.ACh is not 
activated by a cytosolic second messenger, but that the activating system is membrane 
delimited and can not spread over the cell.   
Subsequently, interest was focused on the question of whether the a- or  bg-
subunit of Gi protein activates the channel. While the first investigations suggested the 
a-subunit of Gi to activate Ik.ACh (Yatani et al., 1987), others favored the bg-subunit as 
activator (Logothetis et al., 1987). In addition the bg-subunit was supposed to regulate 
channel opening indirectly via phospholipase A2 (PLA2) activation and subsequent 
release of arachidonic acid (Kurachi et al., 1989). Prolonged (³ 2 min) M2-cholinoceptor 
activation can result in an inhibition of Ik.ACh in a pertussis toxin-insensitive manner 
(Bunemann et al., 2000). This desensitization of the channels did not require 
phosphorylation or internalization of the M2-C R. It was concluded that prolonged M2 
and M4 cholinoceptor stimulation can inhibit bg-su unit-activated Ik.ACh involving non-
pertussis toxin sensitive G protein.  
In human heart, Ik.ACh has been identified in the atrium (Heidbuchel et al., 1990) 
as well as in the ventricle (Koumi and Wasserstrom, 1994). In both tissues Ik.ACh was 
directly activated by ACh. While the channel kinetics and characteristics were similar in 
atrium and ventricle, the two tissues differed with regard to the ED50 of he ACh-induced 
activation of Ik.ACh: in atrium half maximum activation was achieved with 0.03 mM ACh, 
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whereas in the ventricle EC50 was 0.13 mM. In both tissues Ik.ACh was activated via Gi 
protein (Koumi and Wasserstrom, 1994). However this direct Ik.ACh activation in human 
ventricular tissue does not seem to contribute substantially to inotropy since a direct 
negative inotropic effect of muscarinic stimulation is lacking from the human heart. 
There is no evidence for an inhibition of the transient type Ca2+ chann ls by muscarinic 
agonists including ACh (Cerbai et al., 1988). In contrast, L-type Ca2+ channel is 
inhibited by muscarinic stimulation in both atrium and ventricle. However, while in 
atrium no prior elevation of intracellular cAMP concentration is required, in ventricle 
the inhibitory effect on the L-type Ca2+ channel is typically seen only if cAMP has been 
elevated, which has been defined as ‘accentuated antagonism’ (Levy, 1971). In atrial 
cells a concentration-dependent inhibition of L-type Ca2+ channels up to 35 % following 
stimulation with muscarinic agonists or adenosine can be observed if Ik.ACh i  blocked by 
cesium ions otherwise the activation of Ik.ACh would shorten the time window for L-type
Ca2+ channel (Cerbai et al., 1988). However, according to these authors the activation of 
Ik.ACh is the dominant effect over L-type Ca2+ channels inhibition in the atrium. The 
underlying mechanism does not require enhanced cAMP levels and, thus, is not yet well 
understood.  
Besides this ‘direct’ effect on the L-type Ca2+ channel seen only in atrium, an 
‘indirect’ inhibition of L-type Ca2+ channel can be observed after muscarinic 
stimulation. The ‘classical’ view of the underlying mechanism is that muscarinic 
stimulation leads via pertussis toxin sensitive Gi protein to an inhibiti n of adenylyl 
cyclase, thereby decreasing cAMP levels, thus leading to reduction of the previously 
augmented L-type Ca2+ channel (augmentation by isoprenaline, forskolin or 
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isobutylmethyxanthine in frog and guinea pig v ntricle) (Fischmeister and Hartzell, 
1986). L-type Ca2+ channels that have been stimulated with cAMP directly or with 
cAMP-dependent protein kinase can not be inhibited with muscarinic agonists, so th t 
inhibition of formation of cAMP seems to be the obvious xplanation (Hescheler et al., 
1986). As reviewed by Reuter (Reuter, 1983), cAMP elevation leads to the activation of 
protein Kinase A phosphorylating L-type Ca2+ channels which in consequence is 
enhanced. However, alternative pathways for an indirect muscarinic inhibition of L- type 
Ca2+ channel have been postulated. Thus, cGMP dependent effects have been described 
(Hartzell and Fischmeister, 1986) such as cGMP inhibiting L-type Ca2+ channels that 
previously had been increased by cAMP. A role for a c-GMP stimulated 
phosphodiesterase PDE2 has been suggested (Simmons and Hartzell, 1988). In 
additional experiments, it was shown that L-type Ca2+ channels can be inhibited by 
cGMP in a manner independent from changes in cAMP levels (Thakkar et al., 1988). In 
contrast, others could not find an effect of cGMP on L-type Ca2+ channels without prior 
stimulation by isoprenaline or cAMP (guinea-pig v ntricle [Levi et al., 1989]). Besides 
these findings, cGMP dependent activation of cAMP-dependent phosphodiesterase 
(Mery et al., 1993) or activation of cGMP- dependent protein kinase (PKG) finally 
leading to reduction in L-type Ca2+ channels (Mery et al., 1991) have been reported. 
Recently, it has been shown that in guinea pig ventricular cells carbachol inhibits L-type 
Ca2+ channels via cGMP/PKG-dependent activation of an okadaic acid-sensitive protein 
phosphatase. This effect of carbachol could be counteracted by elevated intracellular 
levels of cAMP (Sakai et al., 1999). Similarly Shirayama and Pappano (1996) described 
an inhibition of L-type Ca2+ channels by a cGMP-dependent protein kinase in guinea pig 
ventricular myocytes. While some of the first studies mentioned above were performed 
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in frog heart, more recent studies were carried out using mammalian and human 
cardiomyocytes. Thus, it has been show that L-type Ca2+ channel in human atrium is 
controlled via phosphodiesterase 2 (PDE2) and that inhibition of PDE2 caused increases 
in L-type Ca2+ channels, but only in the presence of GTP (Rivet-Bastide et al., 1997). 
This effect was seen only in human atrial or ventricular myocytes. In addition, the 
effects of muscarinic stimulation on L-type Ca2+ channel and Ik.ACh was inhibited by 
methylene blue (a blocker of guanylylcyclase), in rat ventricular and atrial cells (Abi-
Gerges et al., 1997). However, it should be kept in mind that methylene blue can act as 
an antimuscarinic agent (Abi-Gerges et al., 1997).  
It has been shown that ACh can reduce isoprenaline-induced phosphorylation of 
intracellular proteins (Iwasa and Hosey, 1983) such as troponin (England, 1976) or 
phospholamban (Lindemann and W tanabe, 1985). Reduced phosphorylation, however, 
could also mean increased activity of phosphatases. Indeed, Ahmad et al. (1989) could 
demonstrate an increase in activity of type I phosphatase in guinea-pig ventricle 
following stimulation with ACh. Consistent with that finding, others observed a 
diminution of the indirect ACh-induced negative inotropic effect by NaF, a substance 
which can inhibit protein phosphatases (Neumann et al., 1995). Another substance 
known to inhibit phosphatases, okadaic acid, was shown to prevent the reduction in 
protein phosphorylation induced by ACh (Gupta et al., 1994). A possible functional 
relevance of these findings was demonstrated by Herzig et al. (1995), who showed that 
ACh-induced inhibition of L-type Ca2+ channels involves stimulation of protein 
phosphatase. In the human ventricles, muscarinic stimulation does not seems to directly 
inhibit L-type Ca2+ channels since a direct negative inotropic effect has not been 
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observed (Bohm et al., 1989). However, indirect antagonism on b-adrenergic stimulation 
of contractile force has been found in the human ventricle (Giessler et al., 1999).  
The typical effects of ACh on supraventricular tissue resulting in membrane 
hyperpolarization and slowing of pacemaker activity have been classically attributed to 
the activation of Ik.ACh as the main underlying mechanism (Trautwein, 1981). However, 
it was shown that low concentrations of ACh shift the current activation curve for the 
pacemaker current I¦ to more negative potentials, thus inhibiting I¦ n si us nodal cells. 
This is the opposite of the action of catecholamines (acting via cAMP). It is assumed 
that muscarinic receptor stimulation leads to I¦ inhibition via a pertussis-toxin sensitive 
G-protein, resulting in inhibition of adenylyl cyclase and reduced cAMP production. 
This alters the I¦ availability, since this channel is cAMP sensitive. DiFrancesco and 
Tromba (1988) investigated the concentration-dependent effects of ACh on both 
currents, revealing that at low concentrations (0.01 mM) ACh inhibits I¦ but has no 
effect on Ik.ACh, which is functionally reflected by a slowing of pacemaker rate without 
hyperpolarization, while at concentrations of > 0.1 mM ACh inhibits I¦ and activates 
Ik.ACh, leading to both slowing of pacemaker rate and hyperpolarization. The half-
inactivating concentration (IC50) (for I¦) of ACh was 0.013 mM and IC50 of Ik.ACh was 
0.260 mM in these experiments. This indicates that ACh-mediated inhibition of I¦ 
contributes in aimportant manner to the slowing effect of low ACh concentrations on 
sinus nodal rate (DiFrancesco, 1990). Besides cAMP dependent Gs protein mediated 
regulation of I¦ (with a slow time course as can be expected for an effect involving a 
second messenger) a direct effect of muscarinic cholinoceptor activated Go proteins 
(cAMP independent and with a faster time course) on I¦ has also been supposed (Yatani 
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et al., 1990 a and b). Thus, the effect of ACh on I¦ may comprise two components: a 
slow but large cAMP dependent component and a fast but small cAMP independent 
component caused by coupling of muscarinic receptors with the channel via Go proteins. 
This action seems to be mediated by the a subunit (Yatani et al., 1990 a and b). In 
human heart there is also direct inhibition of I¦ by muscarinic stimulation, as has been 
shown in isolated human atria myocytes using carbachol (Hoppe et al., 1998). In the 
human ventricles this current is also present. However, in contrast to human atrium there 
is no direct effect of muscarinic stimulation on human ventricular I¦ (Hoppe and 
Beuckelmann, 1998).                
ACh hyperpolarizes the vascular smooth muscle cell membrane in an 
endothelium-dependent manner by the release of mediators such as NO, endothelium 
derived hyperolarzing factor, and prostacyclin. ACh-induced hyperpolarization is not 
generated in high extracellular K+ concentration ([K+]°) solution, indicating that vascular 
smooth muscle hyperpolarization by endothelial factors is mediated by K+ ch nnel 
activation, which in turn closes voltage-dep ndent Ca2+ channels, reduces cytosolic Ca2+ 
concentration and induces vasodilatation. NO and endothelium-derived hyperpolarizing 
factor (EDHF)-mediated responses can also involve the Na+, K+-ATP se that is found in 
the plasma membrane of vascular smooth muscle cells (Busse et al., 2002) and is 
thought to be critically involved in the maintenance of cellular ionichomeostas s eeded 
to regulate membrane potential and vascular smooth muscle tone (Marin and Redondo, 
1999). Membrane hyperpolarization and increased cytosolic Ca2+ concentration has been 
reported in endothelial cells stimulated by ACh (Busse et al., 1988). However, BKCa 
blockers have only a marginal effect on cytosolic Ca2+ in endothelial cells, indicating 
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that these blockers most likely act on K+ channels of the vascular smooth muscle cells 
(Yamanaka et al., 1998). To attribute the effects of BKCa channel blocker on ACh 
responses to actions on aortic vascular smooth muscle, Callera et al. (2004) showed that 
Iberiotoxin (IbTX) (big conductance KCa channel blocker) inhibits SNP vasodilatation 
only in endothelium denuded aortic rings from 2-kidney (with no clip) rats without 
affecting the response on vessels from 2K-1C rats. The small conductance KCa hannels 
are involved in the endothelium-dependent relaxation. The association of apamin (small 
conductance KCa channel blocker) andIbTX produced an inhibition of ACh relaxation, 
compared with the effect of IbTX alone, only in aortic rings from 2K-1C ats. The 
higher total mount of intracellular Ca2+ after KCa blockade contributes to the activation 
of small conductance KCa channels in 2K-1C aortas. Therefore, apamin-sensitive KCa 
channels contribute to ACh-induced relaxation, instead of being responsible for the 
impaired ACh response, in aortas from 2K-1C (Callera et al., 2004).       
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1.7.  RATIONALE S OF THE STUDY 
 
1. In a previous study, we demonstrated that nicotine, an exogenous substance, 
stimulated or inhibited, depending on the concentrations, the whole-cell K+ 
channels in rat tail artery SMCs (Tang et al., 1999).  Since the molecular nature 
of K+ channels in the previous study was not clear, the altered whole-cell K+ currents 
in the presence of nicotine could be conducted by Kv channels, KCa channels or KATP 
channels.  It was consequently questioned whether nicotine could interact with KATP 
channels, and more specifically with Kir6.1 subunits. 
 
2. Wang and colleagues (2000a) demonstrated that nicotine blocked multiple types 
of K+ currents (including A-type currents, delayed rectifier current and inward 
rectifier current) with preferential inhibition of transient outward currents 
(I to/Kv4.3) and those results indicate that nicotine is a non- pecific blocker of K+
channels with certain selectivity toward A-type currents. The effects of nicotine 
were independent of nicotine receptor stimulation or catecholamine release and the 
effects were not reversed or prevented by mecamylamine (100 mM, nicotine receptor 
antagonist), atropine (1 mM, muscarinic receptor antagonists), or propranolol (2 mM, 
b-adrenoceptor blocker). Thus the inhibitory effects are likely the consequence of 
direct interactions between nicotine molecules and the channel protein. 
Accumulating evidence has shown that nicotine can also exert its effects wi hout 
involvement of nAChRs and catecholamine release. Studies under conditions devoid 
of nAChR stimulation demonstrated the ability of nicotine to alter action potential 
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(AP) characteristics in guinea pigs (Pappano and Rembish, 1970), rabbits (Carryl et 
al., 192), and dogs (Greenspan et al., 1969) in different tissues such as sinus nodes 
(Satoh, 1997), atrium, ventricle, and Purkinje fibers. The most noticeable changes 
were decreases in resting potential and prolongation of later AP phases. It is 
therefore quite conceivable that nicotine might be able to interact directly with ion 
channels.      
 
3. Mayhan and Sharpe (2002) reported that acute and chronic exposure to 
nicotine has profound affects on vasodilatation induced by activation of KATP 
channels. Chronic exposure to nicotine did not alter vasodilatation induced by 
nitroglycerin but impaired vasodilatation induced by aprikalim and cromakalim 
(KATP channel openers). In nicotine-treated hamsters aprikalim and cromakalim 
failed to dilate he arterioles. In addition, Mayhan and Sharpe (2002) reported that 
acute treatment of the cheek pouch microcirculation with SOD attenuated the effects 
of nicotine on aprikalim and cromakalim induced vasodilatation. Si ce KATP in 
vascular tissues is mainly formed by Kir6.1 subunits, these data suggest that nicotine 
modulates Kir6.1 channels.  
 
4. ACh is an important endogenous neurotransmitter and vascular relaxant. In our 
preliminary study, we applied ACh to HEK-293 cells that expressed heterologous 
Kir6.1 channels. Surprisingly, ACh stimulated Kir6.1 channels.   
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1.8. WORKING HYPOTHESES  
 
1. Nicotine and ACh modulate the function of the stably expressed KATP channel 
subunit (Kir6.1) and such modulation is independent of acetylcholine receptors.  
 
2. Nicotine modulation likely involves mediatory roles of free radicals, particularly 
superoxide anion and such mechanism is not provoked in the ACh modulation of 
the channel. 
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1.9. OBJECTIVES OF THE STUDY  
 
Based on the aforementioned rationales and hypotheses, the following objectives were 
undertaken.     
 
1. To establish a cell line of heterologously expressed Kir6.1 channels in 
HEK-293 cells and to characterize and confirm the expressed Kir6.1 
channels. 
 
2. To study the modulation of cloned Kir6.1 channels by nicotine and the 
underlying mechanisms.   
 
3. To study the effects of O2.- on the expressed Kir6.1 channels. 
 
4. To study the modulation of Kir6.1 channels by ACh and the underlying 
mechanisms.  
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2. GENERAL METHODOLOGY  
 
2.1.  CELL PREPARATI ON 
 
2.1.1.  Stable transfection of HEK-293 cells with Kir6.1 gene 
HEK-293 cells (American Type Culture Collection, Rockville, MD) were 
cultured in 35 mm Petri dishes as described previously (Ca  et al., 2002). The pCR2.1-
rvKir6.1 cDNA clone (GenBank # AB043637) was cleaved with appropriate restriction 
endonuclease to produce the cloned rvKir6.1 subunit gene insert w th proper restriction 
enzyme cleavage sites at both ends.  It was then subcloned into a modified mammalian 
expression HA3 vector (King et al., 2000).  The construct was linearized with Eam 
1105I restriction endonuclease (MBI Fermentas). Linearized construct was mixed witha 
FuGENEÔ 6 transfection reagent (Roche) in a ratio of 1 (mg): 3 (ml) in 100 ml of fetal 
bovine serum (FBS) -free RPMI-1640 medium.  After incubating for 45 min at room 
temperature, the mixture was added to HEK-293 cells in 2 ml FBS-free RPMI medium 
(cell density: 8x104/35 mm dish).  Geneticine (GIBCO) selection was performed at 
concentration of 500 mg ml-1.  Non-transfected HEK-293 cells were included as a 
negative control for antibiotic selection. After 4 weeks of antibiotic selection culturing, 
surviving transfected cells were picked individually into 24-well culture plates for 
proliferation.  When the cells became >90% confluent in 90 mm culture dishes, they 
were harvested and frozen in liquid nitrogen for electrophysiological study. Stable 
transfection took around 6 days to complete: 
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A. Day 1: We washed the stock plate of cells with 5 ml physiological saline 
solution (PBS) and we add trypsin to detach the cells. Then we resuspended the 
trypsinized cells in 10 ml standard media to make an even suspension. In 10 ml PBS we 
made cell suspensions with 10 ml aliquot of the cells. We added 2 ml of fresh standard 
media into three 6.0 cm Petri cell culture dishes (one for transfection, one for vector only 
transfection and one for the negative control). We pipetted the volume of cells into each 
plate containing the media (usually 105 –106 cells for each dish) and we rocked the 
dishes back and forth to distribute the cells evenly over the surface. We incubated the 
dishes overnight in the incubator at 37°C and 5% CO2.     
 
B.  Day 2: We performed the transfection in the second day by preparing the 
following solution in sterile Eppendorf tubes for each Petri dish: Solution A:  300 ml 
non-FBS MEM media plus 2.0 mg DNA (must be of transfection quality i.e, made by 
Qiagen Prep kits or equivalent nd properly linearized). Solution B: 300 ml non-FBS 
media plus 6 ml Fugene6 (Roche) transfection reagent. We combined solutions A and B, 
mixed them gently, and incubated t room temp. for 30 min. We added 2.4 ml non-FBS 
MEM to the cells in the Petri dishes and then gently we added the above combined 
solutions above down to the side of the plates. For the negative control dish, we just 
added 3 ml of non-FBS MEM and incubated as well in the incubator at 37°C and 5% 
CO2 for 6 hours. After 6 hours of incubation we added 3 ml of MEM + 20% FBS + 
pen/strep medium without removing the transfection media and also added the same 
amount of the media to the mock transfected cells and negative control dishes. We 
incubated the cells in the incubator at 37°C and 5% CO2 overnight. 
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C. Day 3: We changed the media and replaced it with normal MEM +10% FBS + 
pen/strep in both transfected dish and control dish. 
 
D. Day 4 to 6-split ing cells and the antibiotic selection: When the transfection 
and the control dish are confluent, we washed the cells with PBS and trypsinized them 
as usual. We resuspende  the cells in 10 ml of selective media for each plate. The 
selective media s the media the cells normally grow in, ith the addition of high 
concentrations of the selection drug. We split these cells onto 10-10 cm dishes by adding 
9 ml of the selective media and 1 ml cell suspension. We rocked the dishes to distribute 
the cells evenly. We allowed the cells to grow at 37°C and 5% CO2 for 7-14 days 
(typically 10 days) while replacing the selective media every 3-4 days, until distinct 
colonies of drug resistant cells can be seen in the transfected dish. Usually the cells in 
the negative control dish hadall died at this point in time, allowing us to discard these 
dish (es). 
 
E. Picking the colonies: We removed the media from all the plates of cells. We 
washed each plate with 5 ml PBS and then aspirated off all the PBS. We examined the 
colonies and selected isolated ones with a marker, choosing no more than 3 colonies 
from each plate. We used sterile forceps to pick up a sterile 3mm filter paper circle and 
dipped it into the freshly made trypsin. We placed this circle directly on top of a cell 
colony that we had previously circled with a marker. T ypsin dislodged the cells from 
the plates.  We prepared 24 well dishes with media. We transfered the paper disk, with 
associated cells, into one of the prepared wells in the 24 well dishes. We rocked the 24 
well dishes to distribute the cells ev nly. We allowed the cells to grow in the incubator 
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at 37°C and 5% CO2 until the cells were confluent. 
 
F. Scaling up the cell colonies for analysis and stocks: When the wells become 
confluent, we split them. Each cell colony was split into 2 samples. A larger cell sample 
on a 6 well plate was used for lysis and analysis. A smaller cell sample was kept on a 
stock plate so that they would be r adily available after Western analysis/patch clamp 
study. Therefore, care was taken ot to contaminate those stocks since they w rethe 
only sample of that particular clonal cell line.  
 
G.  Storage of cell lines: When the cells were confluent, they were harv sted and 
frozen in liquid nitrogen.  
 
2.2. ELECTROPHYSIOLOGICAL  RECORDING OF THE WHOLE-CELL 
K ATP CHANNEL CURRENTS (PATCH-CLAMP TECHNIQUE ) 
 
2.2.1.  Solutions 
The pipette (intracellular) solution contained (mM): 132 KCl, 1.2 MgCl2,  
CaCl2, 10 ethylene glycol-bis(beta- minoethyl ether)-N,N,N',N'- tetraacetic acid 
(EGTA), and 5 Hepes. Na2ATP 0.3 or 5 mM was dded to the pipette solution 
immediately before the experiments.  The bath (extracellular) solution contained (mM): 
40 KCl, 100 NaCl, 2.6 CaCl2, 1.2 MgCl2, and 5 Hepes. Before use, all solutions were 
filtered through a filter with a pore size of 0.22 mm. The pH of both bath and pipette 
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solutions was adjusted to 7.4 with HCl for the bath, and NaOH for the pipette solutions, 
respectively.  
 
2.2.2. Whole-cell recording  
2.2.2.1. Recording and off-line analysis of current cords 
The current traces were digitized us ng a personal computer system. pCla p, 
version 7.0 (software package purchased from Axon Instruments, Inc.) was used to 
record the currents using an Axopatch-200B patch clamp amplifier (Axon Instruments, 
Union City, CA, USA). The output signals were filtered at 1 KHz with an 8-pole filter, 
and stored on the hard disk of a computer for off-line analysis. Depolarization pulses 
were generated by a computer through a digital-to-analog converter (Fig. 2.1) (Wang 
and Wu, 1997; Wang et al., 2000b).  
  
2.2.2.2. Procedures of current recording 
 
Pipette: The pipette for recording in HEK-293 cells was made of borosilicate 
thin wall glass microhematocrit capillary tubes (OD = 1.2 mm, ID = 0.9 mm, Fisher 
Scientific, ON) and had a resistance of 2-4 MW (Wang et al., 2001; Wang et al., 1993). 
These pipettes were pulled by a two-stage electrode puller (Sutter Instruments CO,USA, 
Model P-87).   
 
Seal penetration: The standard gigaohm seal, whole-cell v rsion of the patch-
clamp technique was used to measure whole-cell KATP currents (Sun et al., 2004). A 
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Petri dish with attached cells was mounted on the stage of an inverted phase contrast 
microscope (Olympus, Carsen Group Inc., ON, Canada). The output signals were 
filtered at 1 KHz with an 8-pole filter, and stored on the hard disk of a computer for off-
line analysis. The pipette, which had a small positive internal pressure in order to keep 
the tip clean, was pushed onto the cell surface by using a three dimensional 
micromanipulator (MP-285, Sutter Instrument Company). A tight seal (gigaseal) 
between the membrane and the tip of the pipette (10 to 50 gigaohm) was obtained by the 
application of suction through the pipette (Hanna and Wang 2002). Further suction 
disrupted the membrane under the tip of the pipette, and then the pipette solution 
dialysed the cell. During the process of forming a gigaohm seal between the tip of the 
pipette and the membrane patch, some cells were sucked to such a degree that a gigaohm 
seal could not be achieved. These cells could not be used. The experiments were carried 
out at room temperature (20-22 °C) in order to ensure a longer survival time of patched 
cells and a better time resolution of the membrane currents. The membrane currents of 
HEK-293 cells were amplified by an Axopatch-200B (Axon Instrument, Inc., USA) 
patch clamp amplifier.    
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Figure 2.1. Schematic diagram of whole cell patch-clamp recording.   
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Run-down: In the present study, much effort was devoted to exclude the 
interference of “run-down” of KATP channel currents. Run down is a gradual, variable, 
and probably multifactorial, reduction of channel activity, often associated with 
decreased open probability and increased K1/2,ATP (ATP causing half-maximal inhibition) 
(Kamouchi and Kitamura, 1994). If the current magnitude did not change from the third 
to the fifth minute after the rupture of the cell membrane, th  rate of “run-down” of KATP 
current was usually negligible for 20 min or longer. Cells that had stable KATP currents 
from the third to fifth minute after penetration of the membrane were used. Drugs were 
tested once the whole-cell currents had reached a stable level (i.e. >10 minutes after 
obtaining the whole-cell configuration). If the current decayed too quickly, it was 
difficult to distinguish “run-down” of the current from the inhibitory or excitatory effect 
of the agents. Cells that had a fast decline of KATP currents within this period were 
discarded. A series of voltage steps from –150 to + 80 mV were applied to determine the 
current-voltage relationship.  Current d sity was calculated by dividing the current 
amplitude over the cell capacitance. At the end of the first five minutes the I-V 
relationship was plotted as control (Wang and Wu, 1997). Different drugs were then 
added directly to the bath solution and the change in KATP current was monitored 
continuously. In some cells the bath solution was changed to wash out the tested agent in 
order to determine whether the effects of these agents were reversible. This procedure 
further excluded the influence of “run-down” of K+ channel currents. No allowance, 
hence, was made for the spontaneous decline of KATP current in measuring the effect of 
various agents on KATP channel currents.             
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2.3. MATERIALS  AND WASHOUT PROCEDURE  
 
Stock solutions of nicotine, ACh, cytisine and 1, 1-dimethyl-4-
phenylpiperazinium iodide (DMPP) were prepared in distilled water and protected from 
light. The cells were perfused with the freshly made bath solutions containing the 
desired concentrations of nicotine or ACh. In some experiments, the required 
concentration of the drugs was obtained in a 3 ml bath dish by adding a specific amount 
of the stock solution to the dish. Care was taken that the needed amount of the drugs 
added ranged between 10-30 ml. In some other experiments drugs were added in the 
perfusion system. Only one experiment was conducted per dish. The washout protocol 
was executed to examine the reversibility of the effects of the agents on KATP cha nel 
currents (Wang et al., 1991; Wu et al., 1992). Satisfactory washout of the agent from the 
bath solution was obtained with a perfusion rate of approximately 1 ml/10 sec.       
 
2.4. QUANTIFICATION OF SU PEROXIDE ANION PRODUCTION BY 
LUCIGENIN CHEMILUMIN ESCENCE 
 
 
Generation of superoxide radicals was measured using a LUCY-1 luminometer 
(Kober et al., 2003).  Briefly, HEK-293 cells (2.5 x 106 cells/250 ml) were equilibrated in 
Krebs buffer (pH 7.4, 37°C) for 30 min i  micro-centrifuge tubes in the water bath and 
then 250 mM lucigenin was added to each tube for 5 min.  Thereafter, nicotine at 
different concentrations was added to each tube. Superoxide production in the cells was 
detected after 10 min incubation with nicotine by determining the average luminescence 
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counts for ten measurements with an integration time of 4 s for each measurement.  
Control experiments were included in which cells were incubated with lucigenin for the 
same period of time but no nicotine was added. The background luminescence was 
determined by mixing lucigenin and nicotine in the buffer without cells.  This 
background luminescence had been compensated for i  ll luminescence count results. 
Tempol (4-hydroxy-2,2,6,6-tetramethyl-piperidine-1-oxyl), a novel stable nitroxide 
(antioxidant) (100 µM), was added to the tubes in some experiments before the addition 
of nicotine to quench superoxide anion produced (Fig. 2.2). 
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Figure 2.2. Schematic diagram of the measurement of superoxide anion (O2.-) 
production.  
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2.5. STATISTICAL ANAL YSIS  
 
Unless original traces or single experiments are shown, values are expressed as 
means ± SE. The data from studies on the Kir6.1 currents are expressed as either 
absolute values or percentage of the pre-drug control condition. Concentration-resp se 
curves were fitted to a Hill equation using a computerized curve fitting software 
(Microcal Origin, version 5.0, Microcal Software, Northampton, MA) to obtain the 
concentration at which half-maximal inhibition occurred, IC50.  
The Hill equation is a fundamental expression in chemical kinetics relating 
velocity of response to concentration. It is known that the Hill equation is parameter 
indefinable which means that “perfect data” that is a complete Hill curve, uniquely 
determine the three parameters Vmax, KM, and V (Heidel and Maloney, 1999). The Hill 
equation is frequently used in pharmacology to describe the response of an organism or 
tissue as a function of drug concentrations: 
 Vmax [S]n 
V  =    
KM + [S]n  
 
Where V is the pharmacologic response at drug concentration  [S]n , Vmax is the 
maximum possible pharmacologic response, KM is the concentration of drug at which V 
= 1/2 Vmax and is also a measure of the affinity of the receptor for the drug. The 
parameter n, the Hill coefficient, can be viewed mechanistically s the number of 
molecules that bind to a receptor. More frequently it is regarded functionally as a factor 
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determining the response curve (Heidel and Maloney, 1999; Shen, 2000). The paired 
Student’s t-test or group t-test was used for comparison between mean values of the 
control and those obtained after drug administration. In the case of multiple amplitude 
comparisons, analysis of variance in conjunction with the Newman-Keul’s multiple 
range tests was applied. A significant difference level was set at p< 0.05.   
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3. INTERACTION OF NICOT INE WITH HETEROLOGOU SLY 
EXPRESSED KIR6.1 CHANNELS IN HEK-293 CELLS 
 
3.1. INTRODUCTION  
Consumption of tobacco adversely affects cardiovascular system in humans.  
Increased risk of atherosclerotic vascular di ease, hypertension, myocardial infarction, 
unstable angina, sudden cardiac death, and stroke are among many pathological 
situations associated with tobacco use. The most significant substance that affects 
cellular function in cigarette smoking and smokeles  tobacco is nicotine. Yet the cellular 
effects of nicotine and the underlying mechanisms are still to be clarified.  Nicotine is 
absorbed rapidly through oral mucosa in smokeless tobacco users.  Absorbed nicotine 
may release catecholamine from sympathetic nerve endings.  The subsequent activation 
of a-adrenoceptors in vascular smooth muscle cells (SMCs) contracts vascular tissues 
and elevates blood pressure (Toda et al., 1995).  Nicotine may also act directly on 
vascular SMCs to induce vascular relaxation or contraction (Wang and Wang, 2000).  
These effects of nicotine would contribute to altered cardiovascular function with 
tobacco consumption.  
It has been shown that nicotine has toxic effects on the endothelium (Lin et al., 
1992; Lakier, 1992).  Acute and chronic treatments with nicotine specifically impair 
nitric oxide synthase-dependent vasodilatation and the release of nitric oxide (NO) by 
microvessels (Mayhan and Sharpe, 1999). The mechanism by which nicotine alters the 
NO-dependent response of blo d vessels appears to be related to the production of 
oxygen radicals, which presumably inactivate NO (Raij et al., 2001). It is thus reasoned 
that nicotine may affect cellular functions by altering the oxidative stress level.   
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In addition to synthesis and release of NO, relaxation of blood vessels may also 
occur via activation of KATP channels. KATP channels are closed by increases in 
intracellular ATP. These channels are therapeutic targets for several diseases, including 
angina, hypertension, and diabetes. Stimulation of KATP channels produces 
vasorelaxation and myocardial protection against ischemia, whereas its inhibition 
facilitates insulin secretion. KATP channels are octameric complexes of 2 distinct 
subunits, a sulfonylurea receptor (SUR) and pore-forming Kir6.x subunits (Cao et al., 
2002). SUR confers high-affinity block by sulfonylureas and stimulation by K+ channel 
openers (KCO) and MgADP. ATP inhibits channel activity through an interaction with 
the Kir6.x subunit. The expressed Kir6.1 channel is on y slightly stimulated by iazoxide 
(KATP channel opener) but not inhibited by glibenclamide (KATP channel blocker) 
(Ammala et al., 1996a).  There is also no study reporting the effects of tobacco 
consumption or nicotine on the activation of KATP chanels.  
 
3.1.1. Objectives of this study 
 
In a previous study, we demonstrated that nicotine stimulated or inhibited, 
depending on the concentrations, the whole-c ll K+ channels in rat tail artery SMCs 
(Tang et al., 1999). Coincidently, nicotine also evoked concentration-dependent 
contraction or relaxation of the isolated arterial tissues (Wang and Wang, 2000). Since 
the molecular nature of K+ channels in the previous study was not clear, the altered 
whole-cell K+ currents in the presence of nicotine could b n ucted by voltage-gat d 
K+ channels, calcium-sensitive K+ channels or KATP channels. It was consequently 
questioned whether nicotine could interact with KATP channels, and more specifically 
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with Kir6.1 subunits. Thus, the first goal of the present study was to examine the effect 
of nicotine on the cloned Kir6.1 subunit, which was heterologously expressed in HEK-
293 cells. The second goal was to examine the mechanism(s) by which nicotine 
modulated the function of KATP channels. 
 
 
3.2.  MATERIALS AND MET HODS  
 
3.2.1. Stable transfection of HEK-293 cells with Kir6.1 gene  
 
Details are described in section 2.1.   
 
3.2.2. Electrophysiological recording of the whole-cell KATP channel currents 
 
Details are described in sections 2.2. and 2.3.  
 
3.2.3. Quantification of superoxide anion production 
 
Details were described in section 2.4.   
  
3.2.4. Data analysis 
 
The chemicals we used are listed in page xx under the (List of chemicals). The 
Superoxide production was expressed as count per minute (cpm)/106 cells. Details of the 
statistical analyses are described in section 2.5.  
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3.3.  RESULTS  
 
3.3.1. Properties of the expressed Kir6.1 channel currents  
HEK-293 cells possessed an endogenous background K+ cha nel with current 
density of -3.2 ± 1.4 pA/pF at -150 mV (n = 9). The amplitude of this current did not 
change significantly during 15 min of dialysis with an intracellular solution containing 
0.3 mM ATP. In cells transfected with Kir6.1 cDNA, the whole-c ll current had a 
significantly greater density (-23.9 ± 1.6 pA/pF at –150 mV, n = 6) and this current did 
not rundown after 15 minutes of dialysis with 0.3 mM intracellular ATP (-24.1 ± 1.8 
pA/pF) (Fig. 3.1A). Dialysis of HEK-293 cells expressing Kir6.1 channels with 5 mM 
ATP in the pipette solution caused a decre se in current density although not 
significantly (-22.43 ± 4.7 vs. -16.42 ± 2.3 pA/pF, n = 8-5 for each group, p> 0.05) (Fig. 
3.1B). Inward rectifier K+ (Kir) channels are very sensitive to nhibition by extracellular 
Ba2+ (Nelson and Quayle, 1995). In our experimental conditions Ba2+ at 0.5 mM 
inhibited Kir6.1 currents by 52.5% (Fig.3.2). PNU-37883A, a morpholinoguanidine, is a 
novel KATP channel inhibitor. This compound appeared to have selectivity for the 
Kir6.1-based vascular KATP channel (Kovalev et al., 2004). Application of 30 µM PNU-
37883A to the transfected HEK-293 cells markedly inhibited Kir6.1 currents (-37.4 ± 
2.8 vs. –25.85 ± 2.9 pA/pF at -150 mV, n = 6, p < 0.05). The effects of PNU-37883A 
were reversible (Fig. 3.3).  
The identity of heterolog usly expressed Kir6.1 channel was further confirmed 
using a specific anti-Kir6.1 antibody (Kir6.1 Ab). GST-tagged Kir6.1C fusion protein 
was used as antigen to raise antisera (Sun et al., 2004). The antisera were pre-absorbed
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first with GST protein befor  being used in the following Western blot experiments. A 
single 41 kDa band of Kir6.1 protein was detected in HEK-293 line, which was 
permanently transfected with rvKir6.1 coding cDNA (lane 2 in Fig. 3.4A and B). 
Interestingly, a band with the same molecular mass was also detected in non-transfected 
native HEK-293 (lane 1 in Fig. 3.4A and B).  Quantitative analysis revealed that the 
expression levels of Kir6.1 proteins in the transfected HEK-293 cells were 5.3-fold 
higher than that in non-tra sfected HEK-293, when normalized with b-actin expression 
level (P<0.01) (Fig. 3.4B). Furthermore, the antibody specifically recognized a single 
38 kDa bacterial Kir6.1C–GST fusion protein (Fig. 3.4A, lane 3) and did not cross-react 
with a Kir6.2C–GST fusion protein (Fig. 3.4A, lane 4). After the antibody was pre-
absorbed with Kir6.1 bacterial fusion protein prior to Western blot experiment, positive 
bands in HEK-293 cells disappeared (Sun et al., 2004). When anti-GST antibody was 
used as primary antibody instead of anti-Kir6.1 antibody, only Kir6.1–GST fusion 
protein was detected (Fig. 3.5A). No reaction was observed between anti-GST a tibody 
with any tested cells or tissues (Fig. 3.5A and B).   
We used Kir6.1 Ab to confirm the identity of the expressed Kir6.1 channels. 
Because the Ab and the serum were included in the pipette solution we were not able to 
record the control current as a separate value as we did in all other experiments. 
Therefore, the whole cell recording started after the formation of the whole-cell 
recording configuration (i.e. after membrane break). The control was considered to be 
the first 50 seconds of the recording. After that the effect of the Ab starts to appear due 
to the mixture of the Ab (or the serum) incl ded in the pipette and the intracellular 
cytoplasm. Two minutes after the formation of the whole-cell recording configuration, 
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the cells were repetitively hyperpolarized to –150 mV from a holding potential of –20 
mV with 800 ms pulses applied at 1 kHz. Kir6.1 currents were stable for 15 min of 
recordings in the presence of 1:500 control sera in the pipette solution (Fig. 3.6A). 
Control serum was taken from the same rabbit before immunization with Kir6.1 
antigenic proteins (Sun et al., 2004). With Kir6.1 Ab (1:500) in the pipette solution, 
Kir6.1 currents were inhibited within 10 min after the establishment of the whole-cell 
configuration by 21.3 ± 4.6% (-927.7 ± 25.9 to –729.7 ± 42.9 pA) (Fig. 3.6B). The 
inhibition of Kir6.1 currents became stable 10-15 min thereafter.   
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Figure 3.1. Properties of the endogenous and the expressed Kir6.1 channel currents 
in HEK-293 cells (test potential, -150 mV; holding potential, -20 mV). A. K+ channel 
current in native non-tra sfected and Kir6.1 cDNA transfected HEK-293 cells after 5 
and 10 min of recording with0.3 mM ATP in the pipette solution (n = 9-6).   B. Kir6.1 
currents with 0.3 and 5 mM ATP in the pipette solution (n = 8-5).  
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Figure 3.2.  Effect of Ba2+ on Kir6.1 channels stably expressed in HEK-293 cells. 
Original recordings of Kir6.1 currents before (A) and after (B) the application of 0.5 
mM Ba2+ to the bath solution. C. I-V relationship of Kir6.1 channels before and after 
application of 0.5 mM Ba2+ . D. Summary of the effects of Ba2+ on Kir6.1 channels at -
150 mV. * p <0.05. 
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Figure 3.3.  Effect of KATP channel blocker PNU-37883A on Kir6.1 channels stably 
expressed in HEK-293 cells. A. Original recordings of Kir6.1 currents before, during, 
and after the application of 30 µM PNU-37883A to the bath solution. B. Summary of the 
effects of PNU-37883A on Kir6.1 channels at -150 mV. * p <0.05. 
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Figure 3.4. Detection of Kir6.1 protein in HEK-293. A. Representative Western blots 
with anti-Kir6.1 antibodies. Lane 1, non-transfected HEK-293 cells; lane 2, HEK-293 
cells transfected with rvKir6.1 cDNA; lane 3, Kir6.1C–GST fusion protein; lane 4, 
Kir6.2C-GST fusion protein.  B. Normalized expression levels of Kir6.1 proteins. 
Column numbers bear the same meaning as the corre ponding lane numbers in A. n = 3 
for each group. *P<0.01 for transfected vs. non-transfected HEK-293 cells. (This work 
was done by Dr. Sun as part of collaboration work; Sun et al., 2004) 
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Figure 3.5. Immunological reactions of different preparations to anti-GST antibody. 
A. Representative Western blots with anti-GST antibodies on cultured cells. Lane 1, 
non-transfected HEK-293 cells; lane 2, HEK-293 cells transfected with rvKir6.1 cDNA; 
lane 3, Kir6.1C–GST fusion protein (38 kDa). B. Representative Western blots with 
anti-GST antibody on different tissues. Lane 1, mesenteric artery; lane 2, tail artery; lane 
3, pulmonary artery; lane 4, aorta; lane 5, heart; lane 6, liver; lane 7, spleen; lane 8, 
kidney; lane 9, brain; and lane 10, Kir6.1C–GST fusion protein (38kDa) (This work was 
done by Dr. Sun as part of collaboration work; Sun et al., 2004) 
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Figure 3.6. Effect of anti-Kir6.1 antibody (Kir6.1 Ab) on KATP channels in stably 
transfected HEK-293 cells. Test potential -150 mV; Holding potential, -20 mV. A. 
Kir6.1 currents recorded with control serum in the pipette solution.  The original whole-
cell KATP current traces were shown at the left and schematic representation of the 
depolarization protocol used for recording at the right.  B. Ki 6.1 currents recorded with 
Kir6.1 Ab in the pipette solution.  The original whole-cell Kir6.1 current traces were 
shown at the left and the summary with the numbers of cells denoted at the right. The 
abbreviation of “a.m.b.” stands for “after membrane breaking” into the whole-cell 
recording configuration.    * p<0.05 vs. control (2 min a.m.b.). 
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3.3.2. Effect of nicotine on Kir6.1 channels 
 
Nicotine at concentrations of 30 µM increased the current densities of the inward 
Kir6.1 current from -23.9 ± 1.6 pA/pF to –33.3 ± 1.8 pA/pF, (n = 6; -150 mV; p<0.05) 
(Fig. 3.7). When the membrane potential was set at –50 mV, nicotine at 30 µM also 
caused a significant increase of Kir6.1 currents –4.0 ± 1.0 vs. –7.0 ± 1.3 pA/pF. Nicotine 
at 100 µM increased Kir6.1 currents from -19.1 ± 1.6 pA/pF to –26.7 ± 4.0 pA/pF (Fig. 
3.8). The maximum excitatory effect of nicotine was achieved approximately 1 min after 
nicotine application. The effect of nicotine was irreversible after 5-10 min of washout. 
Nicotine at 300 µM had no effect on Kir6.1 currents (-14.3 ± 4.3 vs. -15.5 ± 4.4 pA/pF 
at -150 mV, n = 4, p>0.05).   
 At 1 mM, nicotine inhibited Kir6.1 currents from –25.5 ± 5.6 to -9.9 ± 2.6 
pA/pF at -150 mV (n = 4, p<0.05). At physiological ranges of membrane potentials, 
nicotine also significantly inhibited Kir6.1 currents. For example, at –50 mV nicotine 
inhibited Kir6.1 current from -5.3 ± 0.9 to –2.4 ± 0.7 pA/pF (p<0.05). This inhibitory 
effect of nicotine occurred gradually and lasted for 15 min in the presence of nicotine.  
Upon washing out nicotine from bath solution for 10 min the inhibitory effect was 
partially reversed (-9.9 ± 2.6 vs. –11.1 ± 6.4 pA/pF, n = 4, p<0.05) (Fig. 3.9). The 
stimulatory and inhibitory effects of nicotine at different concentrations are summarized 
in Fig. 3.10. In non-transfected native HEK-293 cells, 30 µM and 1 mM nicotine had no 
effect on the endogenous background K+ c rrents either at -150 mV (-3.2 ± 1.4 vs. –5.4 
± 1.2 and –4.0 ± 0.9 vs. –4.3 ± 0.8 pA/pF, respectively) (Fig. 3.11) or at –50 mV (-0.6 ± 
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0.2 vs. –0.9 ± 0.2 pA/pF and –0.6 ± 0.1 vs. -0.8 ± 0.1 pA/pF, respectively) (n = 4-5, 
p>0.05). 
To study the involvement of putative nicotinic receptors in the effect of nicotin  
on Kir6.1 channels, two nicotinic receptor agonists were used. Cytisine (100 µM), an 
agonist of the nicotinic acetylcholine receptor (nAChR) containing a4-b2 subunits 
(Kihara et al., 1998), did not cause any change in Kir6.1 currents (-15.3 ± 1.4 pA/pF vs. 
-16.8 ± 2.5 pA/pF, testing potential -150 mV, n = 4, p>0.05).  DMPP, a non-specific 
nAChR agonist, also did not affect Kir6.1 currents at concentrations of 100-500 µM. For 
example, after the application of 100 µM DMPP the inward current was –14.4 ± 2.3 
pA/pF at –150 mV, which was not different from the control (–16.4 ± 1.7 pA/pF, n = 4, 
p>0.05) (Fig. 3.12). 
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Figure 3.7. Effect of 30 µM nicotine on Kir6.1 channels. Original currents recording 
of Kir6.1 channels in control (A) and then application of 30 µM nicotine (B). Currents 
were recorded by voltage steps from –150 to + 80 mV at a holding potential of –20 mV.  
C. I-V relationships of Kir6.1 channels before and after the application of 30 µM 
nicotine. D. Summary of the effect of 30 µM nicotine on Kir6.1 channels (Testing 
potential, –150 mV; Holding potential, -20 mV). * p<0.05 vs. control.  
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Figure 3.8. Effect of 100 µM nicotine on heterologously expressed Kir6.1 channels 
in HEK-293 cells.  Kir6.1 currents recorded in the absence (A) and then presence of 100 
µM nicotine (B). Currents were evoked by voltage steps between –150 and + 80 mV 
from a holding potential of –20 mV. C. I-V relationships of Kir6.1 channels before and 
after the application of 100 µM nicotine. D. Summary of the effect of 100 µM nicotine 
on Kir6.1 channels (Testing potential, –150 mV; Holding potential, -20 mV). * p<0.05 
vs. control.  
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Figure 3.9.  Effect of 1 mM nicotine on Kir6.1 channels. Representative original cell 
recording in control, after application of 1 mM nicotine (A) and during washout (B). C. 
Representative time course of the effect of 1 mM nicotine on Kir6.1 channels (Testing 
potential, -150 mV; Holding potential, -20 mV). D. I-V relationship of Kir6.1 currents 
before and after application of nicotine. * p<0.05 vs. control.   
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Figure 3.10. Summary of the effect of nicotine on Kir6.1 channels. Relative changes 
in mean Kir6.1 currents (a  –150 mV) induced by different concentrations of nicotine. 
Holding potential, -20 mV. * p<0.05 vs. control.  
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Figure 3.11. Effect of nicotine on endogenous whole-cell currents in non-transfected 
HEK-293 cells. I-V relationships of native transmembrane currents before and after the 
application of nicotine at 30 µM (A) and 1 mM (B) were shown. 
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Figure 3.12.  Effect of DMPP on Kir6.1 channels stably expressed in HEK-293 cells. 
Original recordings of Kir6.1 currents before (A) and after (B) the application of 100 
µM DMPP to the bath solution. C. Summary ofthe effects of DMPP on Kir6.1 channels 
at -150 mV. D. I-V relationship of Kir6.1 channels before and after theapplication of 
DMPP. * p <0.05.  
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3.3.3. Effect of nicotine on Kir6.1 channels in the presence of Kir6.1 Ab in the pipette 
solution  
After the inhibitory effect of Kir6.1 Ab on Kir6.1 channels became stable (Fig. 
3.13A), the cells were exposed to 100 µM nicotine, which only induced a 3.2% increase 
in Kir6.1 currents (n = 7, p>0.05) (Fig. 3.13B & C). Similarly, dialysis with 1:500 
Kir6.1 Ab in the pipette solution abolished the inhibitory effect of 1 mM nicotine on 
Kir6.1 current (Fig. 3.14).  
 
3.3.4. Nicotine-induced production of superoxide anion 
In HEK-293 cells permanently transfected with Kir6.1 cDNA, nicotine (100 µM) 
increased the production of O2.-  from 24.6 ± 1.4 to 33.0 ± 1.6 cpm/106 cells (n = 6, 
p<0.05). On the other hand, 1 mM nicotine caused a decrease in the production of O2.- 
from 24.6 ± 1.4 to 9.0 ± 0.5 cpm/106 cells (n = 6, p<0.01).  In the presence of tempol 
(100 µM), the production of O2.-  induced by 100 µM and 1 mM nicotine was decreased 
to 22.8 ± 1.1 and increased to11.6 ± 0.5 cpm/106 cells, respectively (n = 12) (Fig. 
3.15A).  In non-transfected HEK-293 cells, nicotine at 100 mM increased the production 
of O2.-  from 9.4 ± 0.2 to 13.5 ± 0.4 cpm/106 cells (n = 5-8 for each group, p<0.05). 
Nicotine at 1 mM inhibited O2.- production from 9.4 ± 0.2 to 4.6 ± 0.1 cpm/106 cells (n = 
5-8 for each group, p<0.05) (Fig. 3.15B). There was a significant difference in the basal 
level of O2.- production between transfected (24.6 ± 1.  cpm/106 cells) and non-
transfected HEK-293 cells (9.4 ± 0.2 cpm/106 cells) (n = 5-8 for each group, p<0.05).  
 
 
 
  98 
3.3.5. Effects of HX/XO on Kir6.1 channels 
The HX/XO reaction was used as a source of O2.- . When HX (100 µM) alone 
was added to the bath solution, no detectable changes in Kir6.1 currents were observed 
in any of the cells tested. Application of XO (60 mU/ml) in the presence of HX 
significantly increased the amplitude of Kir6.1 currents. The stimulatory effect of 
HX/XO on Kir6.1 channels occurred within 30 s of application and lasted as long as the 
cells were exposed to HX and XO (Fig. 3.16A). A complete recovery of Kir6.1 currents 
to the control level required about 5 min of washout after the first time of the application 
of HX/XO. Kir6.1 channels responded well to consecutive HX/XO stimulations (Fig. 
3.16A). Recovery of Kir6.1 currents again required 5 min of washout after the second 
time application of HX/XO. The stimulatory effect of HX/XO on Kir6.1 current was 
blocked by 100 µM tempol prior to the application of HX/XO to the bath solution (Fig. 
3.16B). The stimulatory effect of 30 µM nicotine on Kir6.1 current was abolished by 
prior application of 100 µM tempol to the bath solution (-28.3 ± 6.1 pA/pF vs. -31.2 ± 
7.3 pA/pF at -150 mV, n = 6-9 for each group, p>0.05) (Fig. 3.16C). 
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Figure  3.13. The stimulatory effects of nicotine on Kir6.1 channels in the presence of 
anti-Kir6.1 antibody (Kir6.1 Ab) in the pipette solution. A. Time-dependent inhibition of 
Kir6.1 channel by Kir6.1 Ab.  B. Kir6.1 currents in the same cell as in A, which was 
subsequently exposed to 100 µM nicotine. C. Comparison of the effects of 100 µM 
nicotine in the absence and presence of Kir6.1 Ab. * p<0.05 vs. control. Kir6.1 currents 
were recorded at -150 mV from a holding potential of -20 mV.  The abbreviation of 
“a.m.b.” stands for “after membrane breaking” into the whole-cell recording 
configuration. 
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Figure 3.14. The inhibitory effects of nicotine on Kir6.1 channels in the presence of 
anti-Kir6.1 antibody (Kir6.1 Ab). A. The time-dependent changes in Kir6.1 current with 
Kir6.1 Ab in the pipette solution and 1 mM nicotine in the bath solution.  B. Comparison 
of the effects of 1 mM nicotine in the absence and presence of Kir6.1 Ab in the pipette 
solution.  * p<0.05 vs. control.  Kir6.1 currents were recorded at -150 mV from a 
holding potential of -20 mV.  
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Figure 3.15. O2.- production in HEK-293 cells permanently transfected with Kir6.1 
cDNA (A) or in non-transfected HEK-293 cells (B).  * p<0.05 vs. control in the same 
group (with or without tempol). # p<0.05 vs. the same treatment in the absence of 
tempol.  Numbers of experiments for eachtreatment are denoted. 
  102 
B
A
C ( - )  tem p o l (+)  tem p o l
X O
H X
X O
H X
5
0
0
 p
A
1 5 0  s
0
2 0
4 0
6 0
8 0
1 0 0
1 2 0
1 4 0
 
(6)
(6)
(6)
(6)
(6)
(9)(9)
 c o n t r o l
 1 0 0  µ M  t e m p o l
 3 0  µ M  n i c o t i n e  +  1 0 0  µ M  t e m p o l   
0
2 0
4 0
6 0
8 0
1 0 0
1 2 0
1 4 0
1 6 0
K
ir
6
.1
 c
u
rr
e
n
ts
 (
%
)
K
ir
6
.1
 c
u
rr
e
n
ts
 (
%
)
*  1 0 0  µ M  H X
  6 0  m U  X O
          1 0 0  µ M  H X
 
 
 
Figure 3.16.  Modulatory effect of O2.- on Kir6.1 channels.  A. Representative current 
records showing changes in Kir6.1 currents in HEK-293 cells induced by sequentially 
applied HX (100 µM) and XO (60 mU/ml).  B. Summary of the effects of HX and XO 
on Kir6.1 channels in the presence and absence of tempol. n = 6.  * p<0.05 vs. 100 µM 
HX.  C.  Summary of the effects of nicotine (30 µM) on Kir6.1 channels in HEK-293 
cells in the presence of tempol (100 µM).  Numbers of cells in each group are denoted.  
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3.4. DISCUSSION  
 
The effects of nicotine on ion channels have only been studied in a few cases.
Wang et al. (2000a) reported that nicotine potently blocked cardiac A-type channels and 
significantly delayed canine ventricular repolarization independent of the selected 
nAChR or mAChR. In cultured rat striatal neurons, nicotine inhibited slowly 
inactivating K+ currents (Hamon et al., 1997). This neuronal effect of nicotine was 
attributed to the stimulation of nicotine receptors because the nicotinic antagonists 
reversed, and nicotinic agonists reproduced the ion channel blockade.  Previous studies 
from our laboratory showed that in rat tail artery SMCs nicotine differentially affect the 
whole-cell K+ channel currents (Tang et al., 1999). At low concentrations (1-100 µM), 
nicotine increased K+ channel currents via the stimulation of nicotine receptors. At high 
concentrations (0.3-3 mM), nicotine inhibited K+ currents due to its direct effect on K+ 
channel proteins since the inhibitory effect of nicotine cannot be abolished by nicotinic 
antagonist. These observations on isolated vascular SMCs were reconciled by a vascular 
contractility study.  Nicotine induced three types of vasoactive responses of isolated rat 
tail artery tissues, i.e., contraction, relaxation, and rebound contraction upon the removal 
of nicotine (Wang and Wang, 2000). Nicotine caused a transient contraction of rat tail 
artery strips in an extracellular Ca2+ dependent and endothelium independent fashion. 
Incubating tail artery tissues with the nicotine receptor antagonist dihydro-b-erythroidine 
hydrobromide at 10 µM did not affect the nicotine-induced vasoconstriction, 
vasorelaxation, or the nicotine withdrawal induced rebound contraction. When the 
concentration of dihydro-b-erythroidine hydrobromide was increased to 300 µM, the 
nicotine-induced vasodilatation, but not the vasoconstriction or the nicotine withdrawal 
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induced rebound contraction, was significantly reduced. Nicotine can also exert its 
cellular effects without the involvement of nAChRs or catecholamine release. Several 
studies performed under conditions devoid of nAChR stimulation demonstrated the 
ability of nicotine to alter action potential characteristics in various species including 
guinea pig (Pappano and Rembish, 1970) and rabbit (Carryl et al., 1992), as well as in 
different types of tissues such as sinus node (Satoh, 1997), atrium, ventricle, and 
Purkinje fiber. This present study is the first one reporting the effects of nicotine on the 
cloned Kir6.1 channel protein. Nicotine at low concentrations (30-100 µM) immediately 
increased, but at millimolar concentrations gradually inhibited, Kir6.1 currents. The 
presence of Kir6.1 Ab abolished both the inhibitory and stimulatory effects of nicotine at 
different concentrations on Kir6.1 currents. Since he K r6.1 Ab was against a 79 aa 
fragment of Kir6.1 at its C terminus (Sun et al., 2004), the interaction of nicotine with 
Kir6.1 channels in the presence of Kir6.1 Ab suggest that this 79 aa C-terminal epitope 
may be the interacting sites of Kir6.1 channel protein with nicotine. 
Cytisine specifically stimulates th  a4-b2 nAChR (Kihara et al., 1998) and 
DMPP induces the non-specific stimulation of nAChRs. These two agonists did not have 
any effect on Kir6.1 currents at the concentrations tested. Northern blot and Western blot 
analysis have shown the absence of nAChRs in native HEK-293 cells (Chavez-Noriega 
et al., 2000). Based on these observations, it was concluded that the interaction of 
nicotine with Kir6.1 channels is independent of nicotine receptors. 
Previous evidence suggests that PNU-37883A, in contrast to other KATP channel 
modulators, does not bind to the SUR subunit (Kovalev et al., 2004). PNU-37883A and 
glyburide works synergistically to inhibit K+ channel opener-mediated vasorelaxation of 
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isolated rabbit mesenteric artery (Ohrnberger et al., 1993). PNU-3788 A does not affect 
pinacidil binding to rat aorta and only blocks glyburide binding nonspecifically at high 
concentration (Loffler-Walz and Quast, 1998). There is a considerable body of 
pharmacological and physiological dat  that suggest that PNU-37883A selectively 
interacts at the vascular but no pancreatic KATP channels. 3H-PNU-37883A showed 
specific, displaceable binding to rabbit mesen eric artery but not to pancreatic rat 
insulin-secreting RINm5F insulinoma cell membranes (Guillemare et al., 1994). In a 
more comprehensive electrophysiological analysis, Wellman et al. (1999) showed that 
PNU-37883A inhibited pinacidil-activated KATP currents in single rat mesenteric artery 
SMCs, but had little effect on those elicited in skeletal or cardiac myocytes. Since 
vascular KATP channels are widely held to be comprised of the Kir6.1 and SUR2B 
subunits, the selective effect of PNU-37883A suggest that Kir6.1 may be the target of 
this compound. Consistent with this notion, Kovalev et al. (2004) have assigned the 
PNU-37883A sensitivity to a carboxyl-terminal region of Kir6.1 (amino acids 200-424). 
Only chimeras including this carboxyl-terminal protein of Kir6.1 show high sensitivity 
to this compound. They have also demonstrated that the region between 200 and 280 
amino acids plays a key role in determining sensitivity to PNU-37883A. Our cloned full-
length Kir6.1 channel cDNA contains the essential amino acids (amino acids 200-4 4) 
as a site of action for PNU-37883A. In our experimental conditions, PNU-37883A 
inhibited Kir6.1currents by 30.9%. Cui et al. (2003) reported 52.4% inhibition for 
Kir6.1/SUR2B by 30 µM PNU37883A. Kovalev et al. (2004) reported a ound 20% 
inhibition of Kir6.1/SUR2B by 10 µM PNU-37883A, consistant with the effect of PNU-
37883A reported in the present study. Four lines of evidence support the conclusion that 
the recorded inward current in our transfected HEK-293 cells is conducted hrough 
  106 
Kir6.1 channel. First, in our previous published paper (Sun et al., 2004) using Western 
blot experiment we detected a single 41 kDa band of Kir6.1 protein in HEK-293 cells 
that were permanently transfected with Kir6.1. The application of anti-Kir6.1 antibody 
specifically recognized a single 38 kDa bacterial Kir6.1C-GST fusion protein and this 
specific antibody did not cross-react with a Kir6.2C-GST fusion protein. After the anti-
Kir6.1 antibody was pre-absorbed with Kir6.1 bacterial fusion protein pri r to Western 
blot experiments, positive bands in HEK-293 cells disappeared. Second, the 
electrophysiological recordings demonstrated that KATP c annels in transfected HEK-
293 cells were significantly inhibited by heanti-Kir6.1 antibody. The inhibitory effect 
of anti-Kir6.1 antibody was specific since the recorded KATP currents did not change in 
amplitude over the same time frame in the absence of the antibody in the pipette solution 
or with the inclusion of control serum. Third, PNU-37883A significantly inhibited 
Kir6.1 currents.  
The nicotine-induced endothelium-dependent vasodilatation was reversed by 
topical application of SOD (Mayhan and Sharpe, 1998).  Modulation of K+ channel 
activity by oxidative stress is important for cellular functions. O2.- have been reported to 
increase KATP channel activity in guinea-pig cardiac myocytes but decrease KATP 
channel opening in cerebral vasculature (Goldhaber et al., 1989; Tokube et al., 1996). 
Both hydrogen peroxide (H2O2) and peroxynitrite (ONOO-) enhance KATP channel 
activity in the myocardium (Ichinari et al., 1996) and in the coronary (Liu et al., 1994), 
renal, mesenteric (Benkusky et al., 1998) and cerebral vascular beds (Wei et al., 1996; 
1998).  
Our study suggests that O2.- may directly stimulate the Kir6.1 channel. Adenine 
nucleotides are metabolized to HX and xanthine. The nicotinamide adenine dinucleotide 
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(NAD+)-reducing enzyme xanthine dehydrogenase is converted to XO in vivo by various 
mechanisms.  Involvement of XO in aggravating oxidative stress seems o involve 
ischemia, when xanthine dehydrogenase is converted into xanthine oxidase, which then 
releases superoxide. The conversion of xanthine dehydrogenase to XO is thought to be 
triggered by the accumulation of large amounts of xanthine that accumulates during 
ischemia because of the breakdown of ATP. The reaction between HX and XO 
generates O2.-, H2O2, and uric acid.  In our patch-clamp study, HX alone did not alter 
Kir6.1 currents and co-application of HX and XO produced a significant increase in 
Kir6.1 currents in all cells tested. This stimulatory effect was abolished by tempol, a 
scavenger of O2.-. A causative relationship between O2.- a d Kir6.1 channel function is 
therefore strongly indicated. 
 At micromolar concentrations, nicotine enhanced superoxi e production (Fig. 
3.15). This may explain the stimulatory effect of nicotine on Kir6.1 channels since 
superoxide anion directly stimulated the Kir6.1 channel (Fig. 3.16A & B) and tempol 
abolished the stimulatory effect of nicotine on Kir6.1 channels (Fig. 3.16C). On the 
other hand, nicotine at millimolar concentrations inhibited basal superoxide production 
(Fig. 3.15). A lower basal level of superoxide anion can be linked to a reduced 
stimulation on Kir6.1 channels. Thus, this would underline the inhibitory effect of 
nicotine on Kir6.1 channels. Whether nicotine can have similar effects on Kir6.2 
subunits is currently unknown since Kir6.2 is incapable of independent expression in 
HEK-293 cells (Ammala et al., 1996b).       
 In summary, our study demonstrated that nicotine at micromolar concentrations 
stimulated, while at millimolar concentrations inhibited Kir6.1 currents. The dual effects 
of nicotine, not mediated by nAChR, are mediated by superoxide levels in the cells. Not 
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only HX/XO-generated O2.- stimulates Kir6.1 channels, scavenging O2.- with tempol also 
abolished the effects of HX/XO as well as nicotine on Kir6.1 channels. Furthermore, 
significant production of O2.- by nicotine was demonstrated.  The results of the present 
study have several important implications. (1) Oxidative stress related to nicotine 
consumption may underlie some cellular changes induced by smoking and/or smokeless 
tobacco usage. (2) Superoxide anions may alter cellular functions by interacting with 
Kir6.1 channels. Further studies using these lines of information will help to better 
understand the modulation mechanisms of KATP channels.  
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4. INTERACTION OF ACh WITH KIR6.1 CHANNELS 
HETEROLOGOUSLY EXPRESSED IN HEK -293 CELLS 
 
 
4.1. INTRODUCTION  
 
Acetylcholine (ACh) is a major neurotransmitter found in parasympathetic nerve 
terminals and its effects on cardiac function are generally inhibitory via activation of 
myocardial muscarinic receptors.   There are two important types of parasympathetic 
(cholinergic) receptors. Nicotinic receptors are found mainly in skeletal muscle and 
ganglial cells. Muscarinic receptors have quite different structures from those of 
nicotinic receptors. Muscarinic receptors are encoded by a number of different genes; 
most important are the M1-subtype, found mainly in autonomic ganglia and the central 
nervous system, M2-subtype in the heart, and M3-subtype in smooth muscle and 
secretory cells. All of these muscarinic receptors are blocked by atropine.    
ATP-sensitive K+ channels (KATP channels) play a crucial role in coupling the 
cell’s metabolic status to its membrane potential, thereby functioning as cellular 
metabolic sensors (Ashcroft and Ashcroft, 1990). KATP channels are regulated by 
intracellular ADP- and ATP-concentrations (Sun et al., 2004; Babenko et al., 1998) and 
plasma membrane phospholipid (Baukrowitz and Fakler, 2000). In addition, diazoxide 
activates the channels, and sulphonylureas like tolbutamide and glibenclamide inhibit 
channel activity (Kozlowski et al., 1989). Based on their central position in metabolic 
and signaling pathways, potassium channels are increasingly recognized as potential 
targets for pharmacological intervention (Sun et al., 2004). One of the best examples of 
this strategy is the successful therapy with sulphonylureas acting on KATP channels in 
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pancreatic beta-cells, increasing their insulin output, and improving the impaired 
regulation of glucose metabolism in diabetic patients (Inagaki and Seino 1998). 
KATP channels have an important role in the regulation of cellular functions. 
However, there is no electrophysiological or pharmacological study reporting the effects 
of ACh on KATP channels.  
 
4.1.1. Objectives of the study 
 
The first goal of the present study was to examine the effect of ACh on the 
cloned Kir6.1 subunit from rat mesenteric artery SMCs, which was heterologously 
expressed in HEK-293 cells. The second goal was to investigate whether the effect of 
ACh was mediated by the traditional pathways of muscarinic receptor stimulation.  
 
4.2. MATER IALS  AND METHODS    
 
4.2.1. Stable transfection of HEK-293 cells with Kir6.1 gene 
Details of the stable transfection are described in section 2.1. 
 
4.2.2. Electrophysiological recording of the whole-cell KATP channel currents 
The whole cell patch- lamp technique was used to record Kir6.1 currents. Details 
of these methods are described in sectio  2.2. 
 
4.2.3. Data analysis 
Details of the statistical analysis are described in ection 2.5. 
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4.3.    RESULTS 
 
4.3.1. Effect of ACh on Kir6.1 channels 
The properties of the expressed Kir6.1 channels in HEK-293 cells and the 
endogenous background K+ channel currents were discussed in section 3.3.1.  We used 
Kir6.1 Ab to identify the expressed current. Ki 6.1 Ab significantly inhibited Kir6.1 
channels (Fig. 4.1A). The inhibitory effect of anti-Kir6.1 antibody was specific since the 
recorded Kir6.1 currents did not change their amplitude over the same time frame in the 
absence of the antibody in the pipette solution or with the inclusion of control serum 
(Fig. 4.1B).  
In the presence of 0.3 mM ATP in the pipette solution, ACh at 10 µM increased 
Kir6.1 current density from -22.4 ± 4.7 to –36.9 ± 5 pA/pF at -150 mV (n = 5, p<0.05). 
The effect of ACh became ven greater when the ACh concentration was decreased to 1 
µM (n = 8, p<0.05) (Fig. 4.2A, B). There was a concentration dependent relationship for 
the stimulatory effect of ACh at 1, 10 and 100 µM (109.6 ± 37.7 %, 66.6 ± 29.5 %, and 
36.7 ± 15.3 %) (Fig. 4.2C). In non-tra sfected HEK-293 cells ACh had no effect on the 
background currents (-4.0 ± 1.1 vs. -4.0 ± 1.4 pA/pF, n = 5, p>0.05) (Fig. 4.3).  
 
4.3.2. Effect of intracellular ATP concentrations on Kir6.1 channels 
To determine whether the ACh stimulatory effect was affected by intracellular 
ATP concentration, we increased the ATP concentration in the pipette solution to 5 mM.  
Kir6.1 currents were smaller, although not significantly, with 5 mM ATP in the pipette 
solution in comparison with the currents with 0.3 mM ATP (-16.4 ± 2.3 vs. -22.4 ± 4.7 
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pA/pF, n = 8-5, p>0.05). ACh at 10 µM still exhibited its stimulatory effect on Kir6.1 
channels (-16.4 ± 2.3 to –25.5 ± 3.8 pA/pF, n = 8, p<0.05) (Fig. 4.4).  
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Figure 4.1. Effect of anti-Kir6.1 antibody (Kir6.1 Ab) on Kir6.1 currents. A. Effect 
of Kir6.1 Ab on Kir6.1 channels in stably transfected HEK-293 cells. Test potential, –
150 mV; Holding potential, -20 mV. Kir6.1 currents recorded with control serum or 
Kir6.1 Ab in the pipette solution. B. The time-dependent effect of Kir6.1 Ab on whole-
cell KATP currents. Current amplitude (I) at –150 mV at each time point was compared 
with those obtained at the beginning of the recording (Ib). Holding potential –20 mV. * p 
< 0.05 vs. control. Number of cells for each experiment is d oted.  
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Figure 4.2. Effect of ACh on heterologously expressed Kir6.1 channels in HEK-293 
cells.  Kir6.1 currents recorded in the absence (A) and then presence (B) of 1 µM ACh.  
Currents were evoked by voltage steps from –150 to + 80 mV with a holding potential of 
–20 mV. C. Normalized changes in mean Kir6.1 currents (at –150 mV) induced by 
different concentrations of ACh. *p < 0.05 vs. control. Numbers of cells for ach
experiment are denoted. D. I-V relationships of Kir6.1 channels before and after the 
application of 1 µM ACh. Holding potential, -20 mV; n = 8.  
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Figure  4.3. Effect of ACh on the background whole-cell K+ currents in non-
transfected HEK-293 cells. A. I-V relationships of background K+ channels 
transmembrane currents before and after the application of ACh t 10 µM. B. Summary 
of the effect of 10 µM ACh on background K+ currents (test potential, -150 mV; holding 
potential, –20 mV).  
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Figure 4.4. The stimulatory effects of ACh on heterologously expressed Kir6.1 
channels with different concentrations of ATP in the pipette solution. A. ACh (10 µM) 
increased Kir6.1 currents with 0.3 mM ATP in the pipette solution (n = 5). B. Summary 
of the effect of 10 µM ACh on Kir6.1 currents (test potential, -150 mV; holding 
potential, –20 mV) with 5 mM ATP in the pipette solution (n = 8). * p<0.05 vs. control. 
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4.3.3. Modification of ACh effect on Kir6.1 channels by different membrane receptors 
 
A general problem in identifying muscarinic receptor subtypes present in a tissue 
is the lack of subtype selective muscarinic antagonists. Thus, it is necessary to use a 
combination of various antagonists. Atropine, a nonselective antagonist of mAChR, at 2 
µM did not alter the stimulation of Kir6.1 channels by 10 µM ACh (-22.1± 4.3 vs. –
36.6 ± 3.1 pA/pF, n = 4) (Fig. 4.5A andB). To exclude the possible involvement of 
other mAChRs, we increased the concentration of atropine to 20 µM and 10 µM ACh 
still stimulated Kir6.1 currents (- 17.4 ± 4.2 vs. –31.5 ± 4.7 pA/pF, n = 4) (Fig. 4.5C and 
D). To evaluate the involvement of other receptors in the effects of ACh, we 
investigated the effect of ACh in the presence of 100 µM mecamylamine (nAChR 
antagonist), 2 µM prazosin (a1 adrenoceptor antagonist), and 1 µM propranolol (a no  
selective b-adrenoceptor blocker) in the bath solution (Wang and Wang, 2000). These 
different blockers had no influence on the stimulatory effect of ACh on Kir6.1 channels 
(Fig. 4.6A). a-bungarotoxin (a-BTX), a specific a1 (Sciamanna et al., 1997) and a7 (Ji 
et al., 2002) nAChR antagonist did not block the stimulatory effect of 10 µM ACh (–
21.2 ± 4.4 vs. –39.0 ± 4.9 pA/pF, n = 4) (Fig. 4.6B). Dihydro-b-erythroidine (DbE) is a 
competitive antagonist of the human a4-b2 nAChRs at micromolar concentrations 
(Tang et al., 1999). Pretreatment of HEK-293 cells with 10 µM DbE did not alter the 
stimulatory effect of 10 µM ACh on Kir6.1 currents (-25.8 ± 4.5 vs. – 43.4 ± 4.3 pA/pF, 
n = 5) (Fig. 4.7).  
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Figure 4.5.  The stimulatory effects of ACh on Kir6.1 channels in stably transfected 
HEK-293 cells. A. Time-dependent stimulation of Kir6.1 channels by 10 µM ACh in the 
presence of 2 µM atropine. Test potential -150 mV; Holding potential, -20 mV. B. I-V 
relationship of Kir6.1 channels (n = 4) with 2 µM atropine in the bath solu ion. Holding 
potential, -20 mV.  C. The original recording of Kir6.1 currents before and after the 
application of 10 µM ACh in the presence of 20 µM atropine in the bath solution. Te t 
potential -150 mV. D. I-V relationship of Kir6.1 channels at control and after application 
of 10 µM ACh with 20 µM atropine in the bath solution.  
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Figure 4.6. The effects of ACh on Kir6.1 channels in the presence of different 
membrane receptor antagonists. A. The original recording of Kir6.1 currents and the I-V 
relationship of Kir6.1 channels before and after application of 10 µM ACh in the 
presence of mecamylamine (100 µM), prazosin (2 µM), and propranolol (1 µM). 
*p<0.05 vs. control. B. The original recording of Kir6.1 currents and the I-V relationship 
of Kir6.1 channels before and after application of 10 µM ACh in the presence of 100 nM 
a- BTX. Holding potential, -20 mV. 
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Figure 4.7. The effects of ACh on Kir6.1 channels in the presence of dihydro-b-
erythroidine (DbE). A. The original recording of Kir6.1 currents. B. I-V relationship of 
Kir6.1 channels before and after the application of 10 µM ACh with 10 µM DbE in the 
bath solution. 
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4.4. DISCUSSION 
We have characterized the stimulatory effect of ACh on Kir6.1 channels tably 
expressed in HEK-293 cells using the whole cell patch-clamp technique. Our major 
novel finding is that ACh stimulates Kir6.1 subunits. This effect is not mediated by 
AChR dependent mechanisms for the stimulatory effect of ACh was not altered by 
muscarinic or cholinergic receptor blockers.  
 Northern blot and Western blot analyses have shown the absence of nAChRs in 
native HEK-293 cells (Chavez-Noriega et al., 2000).  Wong et al. (1995) reported that 
native HEK-293 cells responded to applictions of ACh with slowly activating inward 
currents. The onset of this inward current was delayed approximately 2 seconds 
following drug delivery. In addition, this current exhibited a prolonged time-course, 
typically lasting 15 –20 seconds. When HEK-293 cells were challenged with increasing 
concentrations of ACh, the magnitude of the current increased in a dose-dependent 
fashion. ACh activated these slow responses with an EC50 of 65 ± 13 µM and a Hill 
coefficient near 1. The slow ACh response was inhibited >90% by 1 µM atropine.  This 
study raised the possibility that HEK-293 cells may possess native mAChRs.  On the 
contrary, the expression of mAChRs in HEK-293 cells at the mRNA level or the protein 
level has not been reported, neitherhas receptor binding experiment been done in these 
cells. mAChRs display both excitatory and inhibitory effects on cholinergic 
neurotransmission by coupling to different intracellular signal transduction pathways. 
Whereas the binding of ligands to mAChR subtypes M1, M3 and M5 activates protein 
kinase C (PKC) and the mitogen-activated protein (MAP) kinase pathway, activation of 
M2 and M4 mAChRs is known to inhibit adenylate cyclase (Teber et al., 2004). In our 
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study the effects of ACh on Kir6.1 channels were not altered by mecam lamine (a 
nAChR antagonist), prazosin (an a1-adrenoceptor antagonist), propranolol (a b-
adrenoceptor blocker), atropine (a muscarinic AChR antagonist), and DbE (a 
competitive antagonist of human a4-b2 nAChRs). These results indicate that ACh 
stimulation of Kir6.1 channels is most likely the consequence of the interactions 
between ACh molecules and Kir6.1 channel proteins. Electrostatic and hydrogen 
bonding interactions between ionized amino acids are known to be important for ion 
channel subunit interaction and protein folding.  ACh is a positively charged molecule 
with quaternary group of the choline moiety as its positively charged tail (Sussman et 
al., 1991; Sarri et al., 2004). The pore forming region (H5) of Kir6.1 channel is also 
positively charged due to two arginine residues (Inagaki et al., 1995). Since ACh
molecules cannot pass through cell membranes, it is possible that the positively charged 
ACh interacts with the positively charged H5 region of Kir6.1 protein, causing 
conformational changes of the subunit and channel activation. This speculation awaits 
experimental confirmation.        
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5. GENERAL DISCUSSION 
5.1. PROPERTIES AND CONCENTRATIONS OF NICOTIN E USED IN OUR 
STUDY  
 
Nicotine is the main constituent of tobacco smoke responsible for the elevated 
risk of cardiovascular disease and sudden coronary death associated with smoking 
presumably by provoking cardiac arrhythmia. The concentrations of nicotine used in our 
study ranged from micromolar to millimolar levels. Similar micromolar concentratins
of nicotine have been used in other studies.  Wang et al. (2000a) studied the effect of 
nicotine (100 µM) on K+ channels that were expressed in X nopusoocytes.  Uteshev et 
al. (1996) investigated the effect of 50 µM nicotine on rat hypothalamus neurons.  The 
micromolar concentrations of nicotine used in our study simulate the steady-state pla m  
levels seen in smokers and smokeless tobacco users.  Lin et al. (1992) demonstrated that 
6 weeks of nicotine intake through drinking water at a dose of 5 mg/kg/day yielded a 
mean plasma nicotine level of approximately 1 mg ml-1 (2.2 mM).  This plasma level of 
nicotine is approximately equivalent to the intake of nicotine by a 60-kg heavy smoker 
(40-100 cigarettes per day) (Hui et al., 1997; Lin et al., 1992). A person smoking one 
cigarette absorbs about 1-1.4 mg nicotine (Feyerabend et al., 1985), leading to a blood 
nicotine level of 70 nM (Russell and Jarvis, 1985). Nicotine intake from a smokeless 
tobacco user is even higher.  Regular smokeless tobacco users can intake more than 
1000 mg nicotine daily (Benowitz et al., 1990), which would lead to a plasma nicotine 
level of about 60-1 0 mM. This concentration is comparable to the concentrations used 
in our present study at the micromolar level. The local concentration of nicotine in 
different tissues may be even higher, which is especially important for the smokeless 
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tobacco users. As high as 1 to 10 mM nicotine has been detected in the saliva of snuff 
users (Hoffman & Adams, 1981). Nicotine at millimolar concentrations s ems to be of 
little biological relevance; however nicotine at 61 mM has been used to characterize the 
role of neuronal nAChRs in oral irritation and pain (Carstens et al., 2000).  
It has been assumed, and to some extent has become public health policy, that it 
is less hazardous to smoke cigarettes that deliver a low r yield of tar and nicotine than it 
is to smoke other cigarettes. There is evidence, however, that cigarette smokers regulate 
their inhalation to maintain nicotine intake. Thus switching from high to low nicotine 
cigarettes may result in as great or even greater intake of combustion products which are
as toxic as or even more toxic than nicotine. The use of nicotine chewing gum has been 
proposed to assist with smoking ceasation. This would be expected to result in lower 
intakes of combustion products but as much or more nicotine. The use of chewing 
tobacco and snuff, which deliver considerable amounts of nicotine, is growing. An 
important consideration in evaluating the risks involved in each of the above cases is the 
question of the harmfulness of nicotine, which is still largely unknown. Cigarette 
smoking is known to activate the sympathoadrenal system, increasing heart rate, blood 
pressure, and circulating levels of catecholamines and corticosteriods (Cryer et al., 1976; 
Cryer et al., 1977). Most or all of these actions are believed to be mediated by nicotine. 
Nicotine is distilled from burning tobacco and is carried proximately on tar 
droplets and probably also in the vapor phase, which is inhaled.  Absorption of nicotine 
across biological membranes depends on pH. Nicotine is a weak base with a pKa (index 
of ionic dissociation) of 8.0 (aqueous solution, 25°C). This means that at pH 8.0, 50 % 
of nicotine is nonionized. In its ionized state, such as in acidic environment, nicotine 
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does not rapidly cross membranes. Therefore, the pH of tobacco smoke is important in 
determining absorption of nicotine from different sites within the body. The smoke from 
air-cured tobacco, the predominant tobacco in pipes, cigars, and in a few European 
cigarettes, is alkaline with progressive puffs increasing its pH from 6.5 to 7.5 or higher. 
At alkaline pH, nicotine is largely nonionized and readily crosses membranes. Nicotine 
from products delivering smoke of alkaline pH is well absorbed through the mouth. 
When tobacco smoke reaches the small airways and alveoli of the lungs, the nicotine is 
rapidly absorbed. The rapid absorption of nicotine from cigarette smoke through the 
lung occurs because of dissolution of nicotine at physiological pH (approximately 7.4), 
that facilitates transfer across cell membranes. Concentrations of nicotine in blood rise 
quickly during cigarette smoking and peak at its completion. Armitage and coworkers 
(1975), measuring exhalation of radi labeled nicotine, found that four cigarette smokers 
absorbed 82 to 92% of the nicotine in mainstream smoke, another smoker presumed to 
be a noninhaler absorbed 29%, and three nonsmokers (who were instructed to smoke as 
deeply as possible) absorbed 30 to 66 percent.  
Chewing tobacco, snuff, and nicotine polacrilex gum are of alkaline pH as a 
result of tobacco selection and/or buffering with additives by the manufacturer. The 
alkaline pH facilitates absorption of nicotine through mucous membranes. The rate of 
nicotine absorption from smokeless tobacco depends on the product and the route of 
administration. With fine-ground nasal snuff, blood levels of nicotine rise almost as fast 
as those observed after cigarette smoking. The rate of nicotine absorption with the use f 
oral snuff and chewing tobacco is more gradual. Nicotine is poorly absorbed from the 
stomach due to the acidity of gastric fluid, but is well absorbed in the small intestine, 
which has a more alkaline pH and a large surface area. Bioavailability of nicotine from 
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the gastrointestinal tract (that is swallowed nicotine) is incomplete because of 
presystemic metabolism (first pass metabolism), whereby after absorption into the portal 
venous circulation, nicotine is metabolized by the liver before it reaches the systemic 
venous circulation. This is in contrast to nicotine absorbed through the lungs or 
oral/nasal mucosa, which reaches the systemic circulation without first passing through 
the liver. Nicotine base can be absorbed through the skin. There have been cases of 
poisoning after skin contact with pesticides containing nicotine. Likewise, there is 
evidence of cutaneous absorption of and toxicity from nicotine in tobacco field workers.  
After absorption into the blood, which is at pH 7.4, approximately 69% of the 
nicotine is ionized and 31 % nonionized. Binding to plasma proteins is less than 5%. 
Nicotine is distributed extensively to body tissues with a steady state volume of 
distribution averaging 180 liters (2.6 times body weight). This means that when nicotine 
concentrations have fully equilibrated, the amount of nicotine in the body tissues is 2.6 
times the amount predicted by the product of blood concentration and body weight. The 
pattern of tissue uptake cannot be studied in humans, but it has been examined in tissues 
of rabbits by measuring concentrations of nicotine in various tissues after infusion of 
nicotine to steady state. Spleen, liver, lungs, and brain have high affinity for nicotine, 
whereas the affinity of adipose tissue is relatively low.  
After rapid intravenous injection (i.v.), concentrations of nicotine decline rapidly 
because of tissue uptake of the drug. Shortly after i.v. injection, concentrations of 
nicotine in arterial blood, lung, and brain are high, while concentrations in tissues such 
as muscle and adipose are low. The consequence of this distribution pattern is that 
uptake into the brain is rapid, occurring within 1 or 2 min, and blood levels fall because 
of peripheral tissue uptake for 20 or 30 min after administration. Thereaf er, blood 
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concentrations decline more slowly, as determined by rates of elimination and rates of 
distribution out of storage tissues. 
 
5.2. NICOTINE -INDUCED PRODUCTION OF SUPEROXIDE ANIONS 
 
In HEK-293 cells tably transfected withthe Kir6.1 subunit, nicotine at 100 mM 
increased the production of O2.- while at 1 mM nicotine inhibited O2.- production. There 
was a significant difference in the basal level of O2.- production between the transfected 
and the non-transfected HEK-293 cells. It is possible that the expression of a 
heterologous protein (Kir6.1) is causing compensatory changes in the HEK-293 cells 
leading to the differences in O2.- production. Further experiments are needed to clarify 
this point. Initial experiments indicated that non-transfected HEK-293 cells did not 
exhibit specific [3H](-)-cytisine binding or (-)-nicotine-stimulated 86Rb+ efflux. In earlier 
studies, it has been reported that non-tr nsfected HEK-293 cells had no response after 
the application of agonists including ACh and nicoti e (Gopalakrishnan et al., 1995). In 
our study the nicotine effect is not receptor mediated. Given the reported lack of 
nAChRs or mAChRs in HEK-293 cells, we propose that the effect of nicotine is partially 
due to the production of O2.- and in another part to the direct effect of nicotine on Kir6.1 
channels. In the presence of Kir6.1 Ab in the pipette solution the stimulatory effect of 
100 mM nicotine was abolished in our study. Nicotine at 1 mM exhibited reduced 
inhibitory effect ompared to hat achieved in the absence of Kir6.1 Ab in the pipette 
solution. These results could be explained by two mechanisms. First, Kir6.1 Ab is 
directed against 79 aa fragment of Kir6.1 protein at its C terminus (Sun et al., 2004). 
This specific epitope of Kir6.1 may partici ate in the formation of the K+ permeation 
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pore. Therefore when the pore is blocked, nicotine could not exhibit its effects. This led 
us to the possibility that nicotine and the Kir6.1 Ab may have the same binding site on 
the channel protein.  Second, when Kir6.1 Ab binds to the Kir6.1 channel it may cause 
conformational changes of the Kir6.1 subunit leading to the change of the configuration 
of the channel protein and decrease of the opening of the channel. Further studies about 
the structure of the c annels are n eded to clarify these possibilities.  
In mammalian cells there are two types of KATP channels. Sarcolemmal KATP 
channels and mitochondrial KATP channels. Sarcolemmal KATP channels are responsible 
for setting membrane excitability in response to metabolic stress.  Mitochondrial KATP 
channels are implicated in the regulation of mitochondrial ion and volume homeostasis. 
Mitochondrial KATP channels are the key effectors of cardioprotection. Ischemic 
preconditioning is an endogenous protective mechanism in which brief periods of 
myocardial ischemia and reperfusion render the myocardium resistant to a subsequent 
more sustained ischemic insult (Murry et al., 1986). It has been proposed that in the 
mitochondria, K+ channel openers target mitochondial KATP channels. This conclusion 
was based primarily on the observation that the KATP op ner diazoxide produced a 
cardioprotection effect in isolated rat heart at a concentration which was shown to be 
selective for opening the mitochondrial, not the sarcolemmal KATP channel (Grover et 
al., 1997). In addition, these investigations showed that 5-hydroxydecanoic acid (5-HD), 
a selective mitochondrial KATP channel antagonist, blocked the cardioprotective ffects 
of diazoxide lending further support to their hypotsis. 
It has been proposed that mitochondria contain mitochondrial KATP channels and 
charybdotoxin-sensitive K+ channels. It has not been established whether the 
intramitochondrial K+ concentration is less or greater than the cytoplasmic K+ 
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concentration, and therefore whether opening of mitochondrial K+ channels results in 
potassium influx or release is not very clear. Recent studies have identified candidate 
mitochondrial KATP channel proteins, including a 28-kDa protein that was isolated from 
the heart muscle mitochondria based upon its selective binding to the sulphonylurea 
compound glibenclamide (Szewczyk et al., 1997), and a charybdotoxin-sensitive 
channel (Xu et al., 2002). Mitochondrial KATP channels exhibit a distinct 
pharmacological profile that allows their functions to be studied; they are selectively 
activated by low concentrations of diazoxide and blocked by 5-HD (Jaburek et al., 1998; 
Sato et al., 2000; Liu et al., 2001).  
Liu and colleagues (2003) reported a surprising finding that mitochondria 
apparently release K+ upon exposure to the mitochondrial KATP channel opener 
diazoxide. 5-HD prevented the release of K+ from mitochondria, consistent with efflux 
through mitochondrial KATP channels being a major route of K+ efflux. The cytosolic K+ 
concentration is known to be approximately 145 mM, but the mitochondrial matrix K+ 
concentration has not been established due to methodological difficulties. Thus, 
conflicting data have arisen from different studies (Kowaltowski et al., 2002). Although 
the assumption has been that the intramitochondrial K+ concentration is lower than the 
cytosolic concentration (Debska et al., 2001), the most direct measurements suggest an 
intramitochondrial K+ concentration of 180 mMor greater (Garlid, 1996). As we 
mentioned earlier, nicotine crosses the cell membrane and causes, depending on its 
concentration, an increase or a decrease of O2.- production. According to our knowledge 
there is no reported mechanism of how nicotine could produce its ffect on O2.- 
production. However, the following mechanisms are proposed (Fig 5.1). Firstly, changes 
in the activity of mitochondrial KATP can modulate ROS production and mitochondrial 
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membrane potential. Membrane potential changes causes cytochrome c r lease and the 
production of ROS and specifically in our study O2.-. On the other hand, millimolar 
concentrations of nicotine cause inhibition of mitochondrial KATP channels and decrease 
in the activation of the electron transport chain and decrease of ROS production. 
Secondly, nicotine may trigger mitochondrial membrane permeability changes and t e 
increased production of ROS that may result from mitochondrial membrane alterations. 
Thirdly, nicotine may effect the Ca2+ concentration in the mitochondrial matrix. Ca2+ 
concentration in thecell cytoplasm is 0.1 mM and 1 mM in the mitochondrial matrix. 
Nicotine may change the inner mitochondrial memb ane permeability leading to Ca2+ 
movement to the cytoplasmic space according to its concentration gradient. Ca2+ carries 
two positive charges and its movement outside the mitochondria leads to n increase in
the electrical driving force of H+ ions causing an activation of the electron transport 
chain and an increase in ROS production. Fourthly, it has been proposed that the 
mitochondria contain charybdotoxin-sensitive K+ (KCa) channels (Xu et al., 2002; Liu et 
al., 2003). We have pr viously reported (Tang et al., 1999) that nicotine can modulate 
K+ channels. We propose that at micromolar concentration, nicotine activates 
mitochondrial KCa channel leading to membrane hyperpolarization and an i crease in the 
production of ROS. Nicotine at millimolar concentrations may cause inhibition of the 
mitochondrial KCa channels and mitochondrial membrane depolarization leading to a 
decrease in ROS production. This decrease in ROS production causes an inhibition of 
Kir6.1 channels.   
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Figure 5.1. The proposed signaling pathway for nicotine. Nicotine causes opening of 
the mitochondrial KATP/KCa channels. The eflux of potassium from the mitochondria 
causes it to produce reactive oxygen species (ROS) via the electron transport chain.  
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5.3. MEMBRANE -PERMEABLE RADICAL SCAVENGER TEMPOL  
 
5.3.1. Properties and molecular structure of tempol  
Tempol is a free radic l scavenger that interferes with the formation or the 
effects of many radicals, including O2.- , hydroxyl radicals, and peroxynitrite. Tempol is 
a water-soluble analogue of the spin label tempo, which is widely employed in the 
electron spin resonance spectroscopy. Tempol is a stable piperidine nitroxide of low 
molecular weight (molecular weight, 172) that permeates biological membranes (Fig 
5.2). Nitroxides are a new class of radioprotectors. Nitroxides have been used as contrast 
agents in magnetic resonance imaging and as spin labels for biophysical studies. It was 
the observation that several nitroxides themselves reacted with f e radicals, specifically 
oxyradicals that led to the investigation of these compounds as radioprotectors and 
antioxidants. McDonald and colleagues (1999) investigated the effects of tempol on 1) 
the infarct size caused by regional myocardial ischemia and reperfusion of the heart in 
vivo and in vitro and 2) the cell injury caused by H2O2 in rat cardiac myoblasts. In the 
anesthetized rat and rabbit, tempol reduced the infarct size caused by regional 
myocardial ischemia and reperfusion.  
 
5.3.2. Mechanism of action of tempol 
Unlike recombinant SOD, which is not able to cross biological membranes, 
tempol permeates biological membranes and accumulates in the cytosol. There is some 
controversy as to whether tempol and other stable nitroxides are “SOD-mimetics” or act 
as stoichiometric scavengers of O2.-.  Regardless of its precise mechanism of action, 
there are many studies that document that tempol tenuates the effects of O2.- in vitro. In 
  133 
our study we show that the nicotine effect was partially mediated by O2.- production. The 
stimulatory effect of nicotine was abolished by 100 µM tempol. Although the precise 
mechanism of how tempol could attenu te the effects of nicotine is not clear, we can 
explain it according to the following studies.       
1. Tempol is a water-soluble compound that can permeate biological membranes 
like the cell membrane. There is a small possibility that tempol could mediate its effects 
by affecting the membrane fluidity or solubility. Kir6.1 channels are expressed in the 
plasma membrane thuswhen membrane fluidity or solubility changes it can change the 
properties and the opening and closing of the channels expressed. If this is tru, then the 
effect of tempol is mechanical and not due to its effect of scavenging free radicals. 
However, to our knowledge there are no previous reports or any evidence from our 
present study to confirm this possibility.  
2. It has been suggested that tempol reduces the formation of hydroxyl radicals 
generated in the Fenton reaction by reducing the intracellular levels of ferrous iron 
(Monti et al., 1996). 
3. McDonald and colleagues (1999) have demonstrated that tempol attenuates the 
impairment in mitochondrial respiration caused by H2O2 in rat cardiac myoblasts in a 
concentration-dependent manner. The decline in mitochondrial respiration caused by 
H2O2 in these cells is mediated by the generation of hydroxyl radicals. As tempol does 
not scavenge H2O2, it is likely that tempol prevents the effects of H2O2 by preventing the 
effects of hydroxyl radicals.  
4. The hypothesis that many of the beneficial effects of tempol are due to the ability 
of this agent to scavenge hydroxyl radicals is supported by the following findings. 
Tempol attenuates the impairment in contractility and reduces the release of lactate 
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dehydrogenase caused by H2O2 in freshly isolated, cardiac myocytes of rat. Tempo also 
reduced the formation of hydroxyl radicals and the release of lactate dehydrogenase in 
rat hearts subjected to global myocardial ischemia and reperfusion (Gelvan et al., 1991). 
McDonald and coworkers (1999) proposed that the protective effects of tempol are due 
to the ability of this stable nitroxide radical to fun tion as an intracellular scavenger of 
O2.- and, particularly, hydroxyl radicals.  
5. Nitroxides, such as tempol, can undergo redox reactions to the corresponding 
hydroxylamine anion or oxammonium cation in biological systems as shown by its 
ability to react with O2.-, leading to the formation of H2O2 and molecular oxygen. 
Tempol inhibits the peroxynitrite-mediated nitration of phenolic compounds in the 
presence of a large molar excess of peroxinitrite, suggesting a catalytic-like mech nism 
(Carroll et al., 2000). 
6. The systemic administration of tempol causes systemic vasodilatation (Zollner et 
al., 1997). It is likely that this hypotension is at least in part mediated by the metabolism 
of tempol to hydroxylamine, which is a potent vasodilator. There is also evid nce that 
tempol enhances the bioavailability of NO. Both SOD and tempol increased the signal 
intensity of the hydroxyl radical adduct by accelerating the dismutation of O2.- (Zollner 
et al., 1997).  
7. Monti et al. (2001) investigated the mitochondrial effects of tempol in a human 
promyelocytic leukemic cell line (HL-60). Exposure of these cells to tempol for 24 hrs 
resulted in a decrease in the intracellular and mitochondrial glutathione pools, an 
impairment of oxidative phosphorylation, and a decrease in mitochondrial membrane 
potential. Specifically, tempol affected the function of complex 1 of the respiratory 
chain.      
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Figure 5.2. Tempol (4-hydroxy-2,2,6,6,-tetramethylpiperidine-N-oxyl) is a water-
soluble analogue of the spin label tempo.  
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5.4. HX/XO SYSTEM AND KIR6.1 CHANNELS 
 
In healthy tissue, xanthine oxidase exists as the nicotinamide adenine dinucleotide 
(NAD)+-reducing enzyme called xanthine dehydrogenase. Under normal conditions 
NAD+ accepts electrons without producing any O2.-. Xanthine dehydrogenase is 
converted to xanthine oxidase by various mechanisms. During ischemia, it is converted 
to xanthine oxidase by Ca2+-dependent proteases and sulfhydryl group oxidation. During 
ischemia ATP is catabolized to adenine nucleotides (adenosine diphosphate, adenosine 
monophosphate, and inosine). Adenine nucleotides are further metabolized to 
hypoxanthine and xanthine. Biochemical changes during ischemia are the basis of 
production of ROS.  
Xanthine + xanthine oxidase    O2.- + H2O2 + uric acid      
 
It is important to mention that the above reactions occur in the body under 
ischemic conditions. Under our experimental condition there is no ischemia and we have 
used HX/XO as a source of O2.- production. We have designed our experiments and took 
into consideration the factors that might affect our results. Firstly, in order to detect 
whether there is a signal that is generated from nicotine by itself we included a blank 
composed oflucigenin, nicotine, and buffer. We observed a very low level of detection 
in the blank and that value was subtracted from all the data we presented in our study. 
Secondly, there is the possibility that nicotine might quench the signal of O2.- 
production. That nicotine at micromolar concentration significantly increased O2.- 
production argues against the quenching of the signal by nicotine. We used a cell-free 
system to ensure that the system is working. Using only HX/XO without including any 
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HEK-293 cells demonstrated that there was 7.2 cpm production of O2.-.  However, we 
could have designed another cell-free experiment that includes HX/XO and nicotine. If 
the O2.- production was the same in the presence or the absence of nicotine then this 
would indicate that nicotine has no effect on the signal detection. Thirdly, both the 
HX/XO system and nicotine produce O2.-. It might be argued that HX/XO might produce
such a huge amount of O2.- that the effect on Kir6.1 channels might be non-sp cific. HX 
at 100 mM and 60 mU of XO produce 7.2 cpm of O2.-. Nicotine (100 mM) increased the 
production of O2.- from 24.6 to 33 cpm/106 cells. So the actual increase of the O2.- 
production is 8.4 cpm/106 cells. Therefore, the results are valid and there is no excessive 
production of O2.- by HX/XO system.   
  
5.5. PROPERTIES OF KIR6.1 ANTIBODIES (KIR6.1 Ab)  
 
Subunit-specific anti-KATP channel antibodies are important tools for examining 
the molecular composition and structure-function relationship of native KATP channels in 
vascular SMCs. To date, in limited studies anti-K r6.1 antibodies were produced using 
either synthetic peptides based on short sequences of Kir6.1 gene or Kir6.1-ST fusion 
proteins as antigens. None of these antibodies has been used to study the expression of 
Kir6.1 proteins in the cardiovascular system. Availability of more specific antibodies f r 
the Kir6.1 subunit would greatly facilitate in depth analysis of the expression abundance 
of KATP channel proteins and the structure-f nction relationship of KATP channels in 
vascular SMCs. rvKir6.1 cDNA (Genbank No.: AB043637) (rv stands for rat vascular 
tissue) was isolated from rat mesenteric artery tissues. The cDNA fragment was 
amplified and manipulated biologically to get a new construct that encodes a GST tag 
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and an in-frame 79 aa Kir6.1C fragment (L277-A355) (pGEX-Kir6.1C). The 
recombinant construct was verified by DNA analysis and was sent to the Genbank, and 
the vascular KATP channels homogeneity was confirmed. The sensitivity of Kir6.1 Ab 
antisera was documented as arbitrary absorbance units determined from the 
chemiluscence of optical density (OPD). The titer of the Ab was evaluated based on the 
value of P/N in which P stands for Ab sensitivity and N for OPD absorbance when using 
bovine serum albumin (BSA) instead as control. The titer of Kir6.1 Ab was as high as 
1:1, 280,000 with P/N value ³ 2.1. Kir6.1 Ab has very high sensitivity for Kir6.1 
channels. The possibility that the Kir6.1 Ab used in our study might interact with ion 
channels other than the expressed Kir6.1 channels (like Na+ or Ca2+ ch nnels) in HEK-
293 is very low for the following reasons. Firstly, non-transfected HEK-293 cells do not 
contain endogenous Na+ channels. Therefore these cells are used for stable or transient 
transfection with cDNA encoding Na+ channel proteins (Rao et al., 2004; Cummins et 
al., 2001). Secondly, although Avila et al. (2004) has identified endogenous Ca2+
channel currents in HEK-293 cells, there were no Ca2+ currents recorded under our 
experimental conditions. We have included 10 mM EGTA to chelate in ra ellular Ca2+ 
and inactivate Ca2+ channels. In addition, at the testing potential used in our study (-150 
mV) most of the Ca2+ channels are inactivated. Third, there are no sequence matches 
with other ion channels. This Ab has very high specificity for KATP channels and 
therefore, the possibility that this Kir6.1 Ab might interact with other channels like Ca2+ 
or Na+ channels is very low. 
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5.6.  SUR AND KIR6.1 SUBUNITS EXPRESSION IN HEK-293 CELLS 
  
Kir6.1 and SUR2B are the constituents of the vascular SMCs. Glibenclamide is a 
classical sulphonylurea compound that blocks KATP hannels by binding to the SUR 
subunits. In our study, we used HEK-293 cells as an expression system to express Kir6.1 
channels alone. Although this is not a physiological model, our desire was to investigate 
the effects of nicotine and ACh on Kir6.1 alone. Our future plans are to study the effects 
of nicotine and ACh on HEK-293 cell co-expressed with SUR2B subunits. We did not 
co-express SUR subunits in any of the data presented in this thesis. Molecular biological 
studies from our laboratory showed that, using Western blot analysis that no -
transfected HEK-293 cells do not express SUR protein. However RT-PCR studies 
showed that the SUR subunit was expressed at the mRNA level. These observations 
mean that although SUR subunit is expressed at mRNA level it can not express a 
functional ion channel protein. We have demonstrated that Kir6.1 channels were the 
only subunit expressed in the HEK-293 cells therefore; using glibenclamide as an 
inhibitor was pointless because it bind to SUR subunits. Instead we used PNU-37883A, 
which binds to Kir6.1 subunits.         
 In 1995, several new molecules that were being studied as potential 
insulinotropic agents for the treatment of non-insuli  dependent diabetes mellitus were 
identified as analogs of meglitinide, previously known as the non-sulphonylurea moiety 
of glibenclamide. Three of these molecules, namely repaglinide, nateglinide and 
mitiglinide are or will be soon available for administration to di betic patients. The 
binding of the sulphonyureas to SUR1 assumably inhibits the cooperativity of the 
nucleotide binding folds (NBF)-1 and –2 of SUR1 that induce th  closed state of the 
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KATP channels. Preclinical studies have shown mitiglinide (KAD-1229), a derivative of 
benzylsuccinic acid, to have an immediate and short-la ting hypoglycemic action and to 
increase insulin release from pancreatic b-c lls. Mitiglinide has been shown to displace 
the bound [3H]glibenclamide in the mouse insulin-secreting cell line MIN6 and to inhibit 
the KATP channel currents in these cells (Mogami et al., 1994), suggesting that it 
stimulates insulin secretion by closing the KATP channels by binding to the 
sulphonylurea receptors. Repaglinide is a carbamoylbenzoic acid derivative that has 
been shown to be effective a  blocking b-cell KATP channels and in stimulating insulin 
release from islets and isolated perfused pancreas. Dabroski et al. (2001) demonstrated 
that repaglinide blocks recombinant Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B 
channels, corresponding to the b-cell, cardiac and SMCs types of KATP channels, by 
binding to a site that is located on the SUR subunit. The ability of repaglinide to block 
all three types of KATP channels with similar affinity suggests that they share a common 
binding site.     
 
5.7.  NICOTINE AND ITS EFFECTS ON THE CARDIOVASCULAR SYSTEM  
 
Okamura et al. (1993) reported that in the presence of indomethacin, nicotine 
induced relaxation of the endothelium-den ded dog superficial temporal arteri l st ips. 
Wang and Wang (2000) reported that the vasodilatation of rat tail artery rings was 
observed in the presence of indomethacin. Therefore, the role of prostacyclin (PGI2) in 
the nicotine-induced vasodilatation of rat tail artery can be excluded. It is also possible 
that the nicotine- duced vasodilatation might result from the stimulation of voltage-
dependent K+ channels in vascular SMCs. In addition to directly inhibiting K+ chan els, 
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nicotine has also been shown to significantly increase the amplitude of K+ channel 
currents in rat tail artery SMCs via an indirect activation of nicotinic receptors (Tang et 
al., 1999). To date, no detailed studies on the interaction between nicotine and cloned 
Kir6.1 channels have been published. The present thesis provide  an insight into the 
potential mechanisms underlying the nicotine effect on Kir6.1 stimulation and 
vasorelaxation.  Mayhan and Sharpe (1998) examined the role of oxygen radicals in 
nicotine-induced impairment of endothelium-d pendent reactivity of resistance arterioles 
in vivo. They reported that acute infusion of nicotine markedly inhibited endothelium-
dependent dilatation of resistance arterioles. This finding could not be explained by a 
non-specific effect of nicotine on vascular reactivity, since respo ses to nitroglycerine 
were not altered by infusion of nicotine. In addition they reported that treatment of cheek 
pouch arterioles with SOD prevented nicotine-i duced impairment of endothelium-
dependent vasodilatation. The same authors (Mayhan and Sharpe, 1999) reported that 
chronic injection of nicotine for 2-3 weeks impaired endothelium-dependent, but not 
endothelium-independent, dilatation of resistance arterioles. In addition, they reported 
that treatment of the cheek pouch microcirculation with SOD reversed nicotine-induced 
impairment of endothelium-dependent vasodilatation. The effect o  nicotine from 
cigarette smoke extracts on the alteration of arteriolar dilation in vivo in response to 
stimulation of KATP channels was studied by Mayhan and Sharpe (1996). High 
concentrations of nicotine (0.5% and 1%) impaired dilatation of cheek pouch arterioles 
to activation of KATP channels and adenylate cyclase. The finding of that study suggests 
that exposure of resistance arterioles to components of cigarette smoke alters important 
cellular vasodilator pathways. Many previous studies have examined the effects of 
activation of KATP channels on large peripheral and cerebral blood vessels in vitro and in 
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vivo. In addition, Mayhan (1993) and others have examined the effects of activation of 
KATP channels on peripheral resistance arterioles. In general, activation of KATP channels 
with cromakalim, pinacidil, nicorandil, and aprikalim produces marked relaxation and/or 
dilatation of arteries and arterioles. Relaxation and dilation of arteries and arterioles in 
vivo and in vitro appear to be specific because glibenclamide inhibits responses to 
activation of KATP channels. Furthermore, Mayhan (1993) has shown that dilation of 
cheek pouch arterioles in response to activa ion of KATP channels with aprikalim and 
cromakalim is not altered to the synthesis/release of NO or a NO-containing compound. 
To determine the role of nicotine treatment on reactivity of cheek pouch arterioles to 
activation of KATP channels, Mayhan andSharpe (2002) examined the response to the 
KATP channel openers, aprikalim and cromakalim. They reported that acute and chronic 
exposure to nicotine impaired the dilatation of resistance arterioles to activation of KATP 
channels. In addition, they reported that acute treatment of the cheek pouch 
microcirculation with SOD attenuated the effects of nicotine on dilatation of cheek 
pouch arterioles in response to activation of KATP channels. All of the above studies 
correlated the nicotine-induced impairment of vasodilatation in response to KATP channel 
activation to free radical production. Mayhan and Sharpe (2002) reported that treatment 
of the cheek pouch microcirculation with SOD reversed nicotine-in uced mpairment of 
endothelium-dependent vasodilatation. H wever, none of the above mentioned studies 
measured the production of O2.-. They reported that nicotine caused impairment of the 
vasorelaxation induced by KATP channel activation. Nicotine-induced impairment of 
relaxation was due to free radical production. SOD treatment reversed the nicotine 
effect. The second important difference betwe n our studies and Mayhan’s study is that 
their study is in vivo study. They measure the diameter of cheek pouch microcirculation 
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and it was important in that study to keep he ndothelium intact. In our study we 
reported the effect of nicotine on Kir6.1 channels in HEK-293 cells where no 
endothelium cells are involved. Thirdly, the presence of SUR2B in the cheek pouch 
arteriole is warranted because as we mention earlier, Kir6.1/SUR2B is the major KATP 
channel in vascular SMCs (Cao et al., 2002). The above m ntioned studies support our 
present data in this thesis that nicotine at higher concentrations causes vasoconstriction 
of the vascular tissue. While in our study we have focused on the expressed Kir6.1 
subunits in HEK-293 cells, further experiments are needed to stu y Kir6.1 coexpressed 
with the SUR2B subunit to address the effects of nicotine on Kir6.1/SUR2B.      
Our data in the present thesis is the first to provide the mechanisms for the effect 
of nicotine on KATP channels. Indeed, we have reported here that at micromolar levels 
nicotine increased the production of O2.- while at millimolar concentrations it inhibits 
O2.- production. Nicotine crosses the cell membrane and causes the production of O2.- in
cytochrome b in the electron transport chain in the mitochondria. In the mitochondrion 
of eukaryotes and in aerobic prokaryotes, cytochrome b is a component of respiratory 
chain complex III - also known as the bc1 complex or ubiquinol-cytochrome c 
reductase. In plant chloroplasts and cyanobacteria, there is an analogous protein, 
cytochrome b6, a component of the plastoquinone-plastocyanin reductase, also known as 
the b6f complex. Cytochrome b/b6, is an integral membrane prot in of approximately 
400 amino acid residues that probably has 8 transmembrane segments. In plants and 
cyanobacteria, cytochrome b6 consists of two subunits encoded by the petB and petD 
genes. The sequence of petB is colinear with the N-terminal part ofmitochondrial 
cytochrome b, while petD corresponds to the C-terminal part. Cytochrome b/b6 non-
covalently binds two heme groups, known as b562 and b566. Four conserved histidine 
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residues are postulated to be the ligands of the iron atoms of these two heme groups. The 
produced O2.- causes stimulation of Kir6.1 channels. This is supported by our finding 
that HX/XO system caused stimulation of Kir6.1 channels when applied to the cells. 
This may partially explain the stimulatory effect of nicotine on Kir6.1 chan els since 
O2.- directly stimulated Kir6.1 channels and tempol abolished the stimulatory effect of 
nicotine on Kir6.1 channels. Another part of the stimulatory effect of nicotine could be 
mediated by the direct effect of nicotine on Kir6.1 channels. On te other hand, nicotine 
at millimolar concentrations inhibited the basal O2.- production. A lower basal level of 
O2.- can be linked to a reduced stimulation of Kir6.1 channels. Thus this would underlie 
the inhibitory effect of nicotine on Kir6.1 channels. The same explanation can be applied 
to understand the millimolar inhibitory effect on Kir6.1 channels. Nicotine at millimolar 
concentrations inhibited the production of O2.- and it even inhibited the basal production 
of O2.-, causing  inhibition of Kir6.1 currents. Another part of the inhibition may be 
caused by direct inhibition of Kir6.1 channels.  
  
5.8.  EFFECT OF ACh ON KIR6.1 CHANNELS PERMANENTLY  
EXPRESSED IN HEK-293 CELLS. 
 
In my thesis we investigated the effect of an endogenous neurotransmitter, ACh 
which shares some characteristics with nicotine, such as the stimulation of ion channels 
through nicotinic and muscarinic AChRs. Our results cl arly show that ACh can 
stimulate Kir6.1 channels. We hypothesize that the SUR2B subunit may mask the 
stimulatory effect of ACh on KATP channels in vascular SMCs. There are two 
possibilities to explain that hypothesis. Firstly, the e are two binding sites for ACh, one 
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on the Kir6.1 subunit and the other one on th SUR subunit. Binding to those two 
subunits causes conformational changes in the channel pore leading to blockage of the 
channel. Secondly, there is only one binding site and it is on Kir6.1 subunit. When the 
SUR subunit is expressed it causes changes in the three dimensional structure of the 
channel pore that masks the stimulatory effect of ACh. In order to investigate the 
hypotheses we need to establish a cell line that co-expresses the Kir6.1 and SUR2B 
subunit. We would also need to compare that with the effect of ACh on SMCs isolated 
from mesenteric arteries or aorta because the major constituent of KATP channels in these 
tissues is Kir6.1/SUR2B (Cao et al., 2002). On the other hand, SUR2B by itself cannot 
function as a channel for the lack of the pore forming region in the SUR2B subunits.   
Another concern is the relevance of our study to cardiac KATP channels. As 
mentioned above, the KATP channel reconstituted by Kir6.2 and SUR2A exhibits a single 
channel conductance of ~ 80 pS and is closed by glibenclamide (IC50, ~ 150 nM) and by 
tolbutamide very weakly (IC50, ~ > 100 mM), and is opened by the KCO pinacidil (EC50, 
~ 10 nM). In contrast, diazoxide does not activate Kir6.2/SUR2A channels (Inagaki et 
al., 1996). All of these characteristics are consistent with those of the KATP channels
recorded in native cardiomyocytes, suggesting that Kir6.2 and SUR2A comprise the 
cardiomyocyte’s KATP channel. However, several reports suggest the 
heteromultimerization of Kir6.1 and Kir6.2 subunits within the same channel complex 
(Kono et al., 2000) while others do not (Seharaseyon et al., 2000). Thus, the molecular 
structure of the pore-f ming subunit of the KATP channel in native cardiomyocytes has 
remained controversial. To clarify the molecular structure of the pore subunit of the 
sarcolemmal KATP channel in heart, cardiomyocytes from both Kir6.1 null mice (Kir6.1-
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1-) and Kir6.2 null mice (Kir6.2-1-) were examined (Miki et al., 2002). KATP channel 
currents (single-channel conductance, ~ 79 pS) were found to be sensitive to ATP and 
glibenclamide in membrane patches of wild-type but not in Kir6.2-1- cardiomyocytes. In 
whole-cell membrane recordings, pinacidil produced an outward current that was 
inhibited by glibenclamide, confirming that it flows through KATP channels in wild type 
cardiomyocytes but not in Kir6.2-1- cardiomyocytes. These findings demonstrate directly 
that Kir6.2 is essential for sarcolemmal KATP channel function in cardiomyocytes. This 
was further confirmed by Kir6.2 rescue experiments. In neonatal myocytes of Kir6.2-1- 
mice, adenoviral gene transfer of Kir6.2 restored the plasma membrane KATP channel 
current that was activated by P-1075 and blocked by HMRI 1098, which are a specific 
activator and a blocker, respectively, of the sarcolemmal KATP channel (Suzuki et al., 
2001). Since the KATP channel in cardiomyocytes was absent in Kir6.2-1- mice but 
present in Kir6.1-1- mice, Kir6.2 is an essential constituent of the KATP c annels in 
cardiomyocytes. The main goal of the present thesis is to study the effect of nicotine and 
ACh on Kir6.1. Since the main subunit of KATP channels in the cardiac sarcolemma is 
Kir6.2, the relevance of our results to cardiac sarcolemmal KATP channels is weak.     
Cardiac myocytes contain two distinct KATP channels: the classic one in the 
sarcolemma (Noma, 1983) and another in the mitochondrial inner membrane 
(mitochondrial KATP channels) (Inoue et al., 1991). Lethal injury to the heart can be 
dramatically blunted by brief conditioning periods of ischemia. Such “ischemic 
preconditioning” effect (Murry et al., 1986) exists in all species examined, including 
humans (Cohen and Downey, 1993). Although the cardioprotection was originally 
attributed to sarcolemmal KATP channels, recent evidence has pinpointed mitochondrial 
KATP channels as the key effectors of cardioprotection (Garlid et al., 1997). 
  147 
Mitochondrial KATP channels are demonstrated to be composed mainly of Kir6.1/SUR1 
by their pharmacological profile.  The interaction of Kir6.1 with nicotine and ACh 
demonstrated in this study may also shed light on the regulation of mitochondrial KATP 
channels.  
It has been demonstrated that ACh mimicked ischemic preconditioning in 
anesthetized dogs. Liu and Downey (1993) showed that ACh mimics preconditioning in 
isolated rabbit hearts. Yao et al. (1999) demonstrated that activation of cardiac 
mitochondrial KATP channels increases mitochondrial ROS signaling, thereby activating 
an important intracellular signaling pathway by which ACh and preconditioning protect 
against ischemia reperfusion injury.  In our present study, nei her mitochondrial KATP
channels, nor ischemic preconditioning, which is mainly due to mitochondrial KATP 
activation were studied.   
In my thesis we propose a new pathway for the modulation of KATP channels by 
ACh. There are several important conclusions from our data. First, ACh had no effect on 
the endogenous K+ channel currents in HEK-293 cells. Second, ACh stimulated Kir6.1 
channels in a dose-dependent manner (Fig. 4.2). Third, the stimulatory effect of ACh 
was not dependent on ATP level in the cells. The latter conclusion was based on the 
following two lines of evidence. 1) Intracellular ATP concentration in these studies was 
clamped at a fixed level (0.3 mM) by dialyzing cells with the pipette solution. 2) 
Intentionally varying ATP concentrations inside the cells (from 0.3 to 5 M) did not 
change the excitatory effect of ACh on KATP channels although it decreased the basal 
level of Kir6.1 currents (Fig. 4.4). Fourth, the excitatory effect of ACh on Kir6.1 
channels is not mediated by an ACh receptor-d p ndent mechanism, as had been usually 
previously believed because the stimulatory effect of ACh is n t blocked by atropine. 
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Fifth, in our study the effects of ACh were not altered by mecamylamine (an nAChR 
antagonist), prazosin (an a1-adrenoceptor antagonist), propranolol (a b-adrenoceptor 
blocker), atropine (a muscarinic AChR antagonists), a- BTX (a specific blocker of a1 
and a 7 nAChRs), and DbE (a competitive antagonist of the human a4-b2 nAChRs). 
These results indicate that ACh stimulation of Kir6.1 currents is most likely the 
consequence of the interactions between drug molecules and channel proteins.  
 The effect of ACh on KATP channels may represent an important endogenous 
mechanism in SMCs, heart, neurons, and other excitable cells to couple cellular 
metabolism to excitabil y. By demonstrating the role of ACh as a novel opener of KATP 
channels we begin to understand how the interaction of ACh with Kir6.1 subunits 
provides an integrated regulation of vascular tone. Kir6.1 subunits are the major 
component of the mitochondrial KATP channels therefore our study will provide a better 
understanding of the ACh effect on cardiac myocytes.  
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5.9. SUMMARY AND CONCLUSI ONS    
 
My thesis presents two important discoveries. First, nicotine, an exogenous 
substance, at micromolar concentrations stimulated, while at millimolar concentrations 
inhibited Kir6.1 channels. Nicotine at micromolar levels increased the production of O2.- 
while at millimolar level inhibited its production. The effects of nicotine were 
independent of nicotine receptor stimulation or catecholamine release under our 
experimental conditions. The nicotine effects are likely partially the consequences of 
O2.- production, and partially through interactions between nicotine and Kir6.1 channels. 
Second, we found that ACh, an endogenous substance released in the body, can dose-
dependently activate Kir6.1 channels heterologously expressed in HEK-293 cells. The 
stimulatory effects of ACh were not blocked by various nicotinic and muscarinic AChR 
blockers. This is an important new finding because it challenges the traditional well-
known pathways of ACh effect through muscarinic and nicotinic AChRs.  
Although some synthetic compounds are currently available to open or close 
KATP channels for the purpose of experimental or clinic l app cations, it is still not quite 
clear where the exact binding sites for these compounds are and whether they areon the 
Kir6.1 or the SUR subunits. For example, drugs which are used for the treatment of type 
II diabetes (non insulin dependent diabetes mellitus) earn their importance by their 
specific binding to SUR2A subunits of KATP channels in the b-cells of the pancreas. The 
present study provides evidence that nicotine may be an exogenous and ACh may be an 
endogenous modulator of Kir6.1 subunits in various tissues. Results derived from this 
thesis concerning different effects of nicotine and ACh and their mechanisms of action 
on Kir6.1 channels indicate the importance of the site of action of these two modulators 
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and have led to more critical evaluation of the mechanism of their actions. This study 
will also stimulate interest in the identification of other endogenous and exogenous 
substances responsible for the modulation of Kir6.1 channels.                                
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6. FUTURE DIRECTIONS  
 
To extend and expand our findings reported in this thesis, the following experiments are 
being developed.  
 
1. Although the effects of nicotine and ACh on K+ channels have been studied, no 
study has investigated the effects of nicotine and ACh on the co-expressed Kir6.1 
and SUR2B channels in HEK-293 cells.  Under physiological conditions, the Kir6.1 
subunit is co-expressed with either SUR1 or SUR2 subunits in native mammalian 
cells.  It is highly possible that in vascular smooth muscle cells Kir6.1 and SUR2B 
are the major components of the native KATP channel complex (Cao et al., 2002). It is 
known that ACh causes vascular tissue relaxation in vitro in the presence of 
endothelium via the production of NO. After the endothelium is removed, ACh does 
not induce a relaxation or contraction of SMCs.  Our results show that ACh 
stimulated Kir6.1 subunit of KATP channels. Opening of KATP channels would cause 
vasorelaxation. The possible explanation for the discrepancy between our cellular 
study and the failure of ACh to alter vascular contractility could be ascribed to the 
presence of the interaction of Kir6.1 and SUR2B subunits in the native vascular 
SMCs. 
   
2. At least 7 subfamilies are now identified for the inwardly rectifying K+ channels
designated Kir1.0 - 7.0 (Okuyama et al., 1998). Reconstitution studies have shown 
that different combinations of Kir6.1 or Kir6.2 and SUR1 or SUR2 variants generate 
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different K+ currents. Therefore, whether nicotine and ACh modulate these channels 
needs to be address d.                       
 
3. Interaction between ROS and K+ channels has been studied extensively at the 
pharmacological level. Although significant advances have been made in 
determining the primary structure of a variety of K+ channels, our knowledge about 
the precise sites altered by ROS is still quite limited. Development of specific clones 
of Kir6.1 channel with mutations at different sites of the amino acid structure, 
combined with molecular techniques and pharmacological function studies, should 
help reveal molecular mechanisms by which ROS modulates KATP channel function.  
As we mentioned earlier, KATP are composed of Kir and SUR subunits.  It is not 
clear how ROS interacts with Kir6.x or SUR subunits.  Whether other ROS, in 
addition to superoxide anion, also interact with Kir6.1 is unknown.  These questions 
need to be answered.  
    
4. In the present thesis we used HEK-293 cells as a tool to investigate the effects of 
nicotine and ACh on Kir6.1 channels.  Eventually, we wish to extrapolate our 
discoveries to the native cells that constitute the cardiovascular system, such as 
vascular SMCs or cardiac myocytes. 
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